Cardiology VIVA:
MASTER LIST 100 (PROCEDURES, DEVICES & CLINICAL SIGNS )
PROCEDURES & DEVICES (X-RAY / FLUOROSCOPY)
1. Permanent Pacemaker (PPM)
Diagnosis: Permanent Pacemaker (Single or Dual Chamber).
Pathognomonic Sign: Radiopaque generator shadow in the pre-pectoral region with thin pacing leads terminating in the Right Atrium (appendage) and/or Right Ventricle (apex or septum).
Clinical Risk: Lead dislodgement, pocket infection, pneumothorax (post-insertion).
Management: Device interrogation to check battery life, lead impedance, and capture thresholds.
Cross-Examination (5 Q&A):
Q: How do you identify an active fixation lead on X-ray? A: Look for a tiny deployed corkscrew (helix) at ead tip.
Q: What is Twiddler's syndrome? A: Patient manipulation of the generator causing leads to coil and dislodge.
Q: Where should the RV lead tip ideally be placed for physiologic pacing? A: The RV mid-septum (avoids LBBB-like dyssynchrony of apical pacing).
Q: What does the first letter in the NBG pacemaker code stand for? A: Chamber paced (A, V, or D).
Q: Is it MRI conditional? A: Requires checking the specific generator and lead models, and programming to a safe mode prior to scanning.
2. Implantable Cardioverter-Defibrillator (ICD)
Diagnosis: ICD.
Pathognomonic Sign: Thick, radiopaque shock coils on the right ventricular lead (located in the SVC and/or RV).
Clinical Risk: Inappropriate shocks, lead fracture.
Management: Device interrogation to review stored electrograms and verify appropriate sensing.
Cross-Examination (5 Q&A):
Q: How do you differentiate a single-coil from a dual-coil ICD on X-ray? A: Single has one thick coil in the RV; dual has an additional coil in the SVC.
Q: What is the primary indication for secondary prevention? A: Survivor of sudden cardiac arrest or hemodynamically unstable VT/VF.
Q: What happens if you place a clinical magnet over an ICD? A: It suspends anti-tachycardia therapies (shocks) but does NOT change the pacing mode.
Q: What is a subcutaneous ICD (S-ICD)? A: Lead is placed over the sternum, generator in the axilla; no intravascular leads.
Q: What is the most common cause of inappropriate shocks? A: Atrial Fibrillation with rapid ventricular response.
3. Cardiac Resynchronization Therapy (CRT)
Diagnosis: CRT Device (Biventricular Pacer).
Pathognomonic Sign: Three leads visible: RA lead, RV lead, and an LV lead coursing posteriorly through the Coronary Sinus.
Clinical Risk: Phrenic nerve stimulation, coronary sinus dissection during placement.
Management: Optimize AV and VV delays via echocardiography.
Cross-Examination (5 Q&A):
Q: What is the target vein for the LV lead? A: A lateral or posterolateral branch of the coronary sinus.
Q: What is the primary ECG indication for CRT? A: LBBB with a QRS duration > 150ms and EF < 35%.
Q: How do you know the LV lead is pacing? A: The paced QRS morphology changes from LBBB to a narrower RBBB-like pattern.
Q: What is the non-responder rate for CRT? A: Approximately 30%.
Q: Complication if the lead is placed too anteriorly? A: Diaphragmatic twitching due to phrenic nerve capture.
4. Amplatzer Septal Occluder
Diagnosis: Transcatheter ASD Closure Device.
Pathognomonic Sign: Radiopaque, double-disk nitinol wire mesh projected over the interatrial septum.
Clinical Risk: Device embolization, aortic rim erosion, residual shunting.
Management: Dual antiplatelet therapy for 6 months, endocarditis prophylaxis.
Cross-Examination (5 Q&A):
Q: Which ASD is amenable to this device? A: Ostium Secundum ASD.
Q: What are the rim requirements? A: At least 5mm of tissue rim around the defect (except the aortic rim, which can be deficient).
Q: Most feared late complication? A: Aortic root erosion causing cardiac tamponade.
Q: When does endothelialization complete? A: Typically by 6 months.
Q: Material of the device? A: Nitinol (nickel-titanium alloy); nickel allergy is a rare contraindication.
5. PTMC Balloon (Inoue)
Diagnosis: Percutaneous Transvenous Mitral Commissurotomy.
Pathognomonic Sign: Dumbbell-shaped balloon inflating across the mitral valve on fluoroscopy.
Clinical Risk: Severe acute mitral regurgitation, cardiac tamponade from transseptal puncture.
Management: Immediate Echo to assess MR severity and residual gradient.
Cross-Examination (5 Q&A):
Q: What is the ideal Wilkins score for PTMC? A: Score < 8.
Q: What are the absolute contraindications? A: LA appendage clot, moderate-to-severe MR.
Q: How does the Inoue balloon inflate? A: Distal half first (anchors in LV), then proximal half (anchors in LA), then the middle (splits commissures).
Q: How do you choose the balloon size? A: Based on patient height.
Q: What indicates a successful procedure? A: MVA > 1.5 cm2 and drop in LAP.
6. Intra-Aortic Balloon Pump (IABP)
Diagnosis: IABP.
Pathognomonic Sign: Radiopaque balloon tip located 2 cm distal to the origin of the left subclavian artery on CXR.
Clinical Risk: Limb ischemia (femoral insertion), aortic dissection, thrombocytopenia.
Management: 1:1 counterpulsation triggered by ECG or arterial pressure waveform.
Cross-Examination (5 Q&A):
Q: What is the hemodynamic effect? A: Decreases afterload (systolic deflation) and increases coronary perfusion (diastolic inflation).
Q: When does it inflate? A: At the dicrotic notch (closure of the aortic valve).
Q: Absolute contraindication? A: Moderate-to-severe Aortic Regurgitation or aortic dissection.
Q: Complication if placed too low? A: Occlusion of renal or mesenteric arteries.
Q: Complication if placed too high? A: Occlusion of the left subclavian artery (diminished left radial pulse).
7. MitraClip
Diagnosis: Transcatheter Edge-to-Edge Repair (TEER).
Pathognomonic Sign: Small metallic clip grasping the mitral valve leaflets.
Clinical Risk: Single Leaflet Device Attachment (SLDA), iatrogenic mitral stenosis.
Management: TEE guidance for precise deployment; monitor transmitral gradients.
Cross-Examination (5 Q&A):
Q: What surgical procedure does this mimic? A: The Alfieri stitch (edge-to-edge repair).
Q: Which leaflet segments are classically targeted? A: A2 and P2 (central scallops).
Q: What is the gradient cutoff before placing a second clip? A: Mean gradient must remain < 5 mmHg.
Q: Primary indication? A: High-surgical-risk patients with severe primary MR or severe secondary MR (COAPT criteria).
Q: How is it delivered? A: Transseptal puncture via the femoral vein.
8. Surgical Valve (Mechanical)
Diagnosis: Mechanical Prosthetic Valve.
Pathognomonic Sign: Distinct radiopaque structures: Ball-and-cage (Starr-Edwards), single-tilting disk (Medtronic Hall), or bi-leaflet (St. Jude).
Clinical Risk: Valve thrombosis, major bleeding (from anticoagulation), hemolysis.
Management: Lifelong anticoagulation with Vitamin K Antagonist (Warfarin).
Cross-Examination (5 Q&A):
Q: Target INR for mechanical aortic valve? A: 2.0 - 3.0.
Q: Target INR for mechanical mitral valve? A: 2.5 - 3.5.
Q: Can you use NOACs/DOACs for mechanical valves? A: Absolute contraindication.
Q: What indicates valve thrombosis on auscultation? A: Muffled or absent mechanical clicks.
Q: How to distinguish pannus from thrombus? A: Pannus is dense/chronic/Echo-bright; thrombus is acute/soft.
9. Transcatheter Heart Valve (TAVI/TAVR)
Diagnosis: TAVR.
Pathognomonic Sign: Large, expandable metallic stent frame housing a bioprosthetic valve in the aortic position.
Clinical Risk: Complete heart block, paravalvular leak, stroke, annular rupture.
Management: Antiplatelet therapy; monitor ECG for PR prolongation or LBBB.
Cross-Examination (5 Q&A):
Q: What are the two main types? A: Balloon-expandable (e.g., Sapien) and Self-expanding (e.g., CoreValve/Evolut).
Q: Which type has a higher risk of heart block requiring a pacemaker? A: Self-expanding valves (due to deeper LVOT penetration).
Q: What causes paravalvular leak? A: Heavy native annular calcification preventing complete stent apposition.
Q: What is coronary obstruction? A: The native leaflet is pushed up over the coronary ostia (requires high implantation or chimney stenting).
Q: Durability compared to surgical valves? A: Current data shows comparable durability out to 5-10 years.
10. Central Venous Line / Lines & Tubes
Diagnosis: Central Venous Catheter (CVC).
Pathognomonic Sign: Radiopaque line with its tip terminating at the cavoatrial junction (where the right heart border meets the SVC).
Clinical Risk: Pneumothorax during insertion, CLABSI (infection).
Management: CXR to confirm position and exclude pneumothorax before use.
Cross-Examination (5 Q&A):
Q: Where is the cavoatrial junction on CXR? A: Approximately two vertebral bodies below the carina.
Q: What happens if the tip is too deep (in the RA)? A: Risk of cardiac perforation and arrhythmias.
Q: Preferred site to minimize infection? A: Subclavian vein.
Q: Preferred site in coagulopathy? A: Internal Jugular (compressible).
Q: How to differentiate arterial vs venous line placement? A: Venous line courses medially down the SVC; arterial line courses into the aortic arch.
11. Swan-Ganz Catheter (Correct Position)
Diagnosis: Pulmonary Artery Catheter.
Pathognomonic Sign: Catheter traversing the RA, RV, and terminating in the proximal Right or LPA.
Clinical Risk: PA rupture, pulmonary infarction (if left wedged).
Management: Ensure balloon is deflated when not actively measuring PCWP.
Cross-Examination (5 Q&A):
Q: What does the PCWP estimate? A: Left Atrial Pressure (and LVEDP if mitral valve is normal).
Q: In what lung zone must the tip reside? A: West Zone 3 (continuous blood flow).
Q: How do you recognize a "wedged" catheter on CXR? A: Tip extends far out into the peripheral lung fields.
Q: Standard indication in cardiology? A: Differentiating cardiogenic from non-cardiogenic shock; pulmonary hypertension workup.
Q: What is a normal Cardiac Index? A: 2.5 - 4.0 L/min/m2.
12. Swan-Ganz Catheter (Malpositioned)
Diagnosis: Malpositioned PA Catheter.
Pathognomonic Sign: Catheter tip curled or terminating in the Right Ventricular shadow.
Clinical Risk: Ventricular Tachycardia (VT), Premature Ventricular Contractions (PVCs), RV perforation.
Management: Immediately deflate balloon (if inflated) and either advance to PA or withdraw to RA.
Cross-Examination (5 Q&A):
Q: What does the RV waveform look like? A: High systolic pressure (e.g., 25 mmHg) with a diastolic pressure dropping near zero.
Q: Why is it highly arrhythmogenic? A: Mechanical irritation of the RV endocardium and conduction system.
Q: What is the RA waveform? A: Low amplitude, typical a, c, and v waves.
Q: What is the PA waveform? A: High systolic pressure, but diastolic pressure remains elevated (e.g., 25/10).
Q: How is placement verified at the bedside? A: Direct waveform analysis during advancement.
13. Endotracheal Tube Position
Diagnosis: ETT Placement.
Pathognomonic Sign: Radiopaque line of the tube terminating 3-5 cm above the carina.
Clinical Risk: Right mainstem intubation, vocal cord injury, hypoxemia.
Management: Auscultate bilaterally; withdraw tube slightly if breath sounds are absent on the left.
Cross-Examination (5 Q&A):
Q: Where is the carina located radiographically? A: Between T4 and T5 vertebrae.
Q: Why does the tube usually enter the right mainstem? A: The right bronchus is wider, shorter, and more vertical than the left.
Q: What happens to the lungs if right mainstem intubation occurs? A: Left lung atelectasis/collapse, right lung hyperinflation.
Q: How does neck flexion affect the tube tip? A: Pushes the tip deeper (caudad).
Q: How does neck extension affect the tip? A: Pulls the tip up (cephalad).
14. Nasogastric Tube Position
Diagnosis: NGT Placement.
Pathognomonic Sign: Tube coursing below the diaphragm with the tip resting in the gastric bubble.
Clinical Risk: Tracheobronchial intubation, aspiration pneumonia.
Management: CXR confirmation is mandatory before initiating feeds.
Cross-Examination (5 Q&A):
Q: What is the "danger sign" on X-ray? A: The tube following the contour of the bronchi into the lung fields.
Q: Can you rely on auscultation (whoosh test)? A: No, CXR is the gold standard.
Q: What is a Dobhoff tube? A: A smaller, more flexible post-pyloric feeding tube with a weighted tip.
Q: Complication of prolonged NGT? A: Esophageal stricture or ulceration.
Q: Should the guide-wire be removed before CXR? A: No, leave it in to increase radiopacity until position is confirmed.
CLINICAL SIGNS (OSCE PHOTOS)
Diagnosis: Permanent Pacemaker (Single or Dual Chamber).
Pathognomonic Sign: Radiopaque generator shadow in the pre-pectoral region with thin pacing leads terminating in the Right Atrium (appendage) and/or Right Ventricle (apex or septum).
Clinical Risk: Lead dislodgement, pocket infection, pneumothorax (post-insertion).
Management: Device interrogation to check battery life, lead impedance, and capture thresholds.
Cross-Examination (5 Q&A):
Diagnosis: ICD.
Pathognomonic Sign: Thick, radiopaque shock coils on the right ventricular lead (located in the SVC and/or RV).
Clinical Risk: Inappropriate shocks, lead fracture.
Management: Device interrogation to review stored electrograms and verify appropriate sensing.
Cross-Examination (5 Q&A):
Diagnosis: CRT Device (Biventricular Pacer).
Pathognomonic Sign: Three leads visible: RA lead, RV lead, and an LV lead coursing posteriorly through the Coronary Sinus.
Clinical Risk: Phrenic nerve stimulation, coronary sinus dissection during placement.
Management: Optimize AV and VV delays via echocardiography.
Cross-Examination (5 Q&A):
Diagnosis: Transcatheter ASD Closure Device.
Pathognomonic Sign: Radiopaque, double-disk nitinol wire mesh projected over the interatrial septum.
Clinical Risk: Device embolization, aortic rim erosion, residual shunting.
Management: Dual antiplatelet therapy for 6 months, endocarditis prophylaxis.
Cross-Examination (5 Q&A):
Diagnosis: Percutaneous Transvenous Mitral Commissurotomy.
Pathognomonic Sign: Dumbbell-shaped balloon inflating across the mitral valve on fluoroscopy.
Clinical Risk: Severe acute mitral regurgitation, cardiac tamponade from transseptal puncture.
Management: Immediate Echo to assess MR severity and residual gradient.
Cross-Examination (5 Q&A):
Diagnosis: IABP.
Pathognomonic Sign: Radiopaque balloon tip located 2 cm distal to the origin of the left subclavian artery on CXR.
Clinical Risk: Limb ischemia (femoral insertion), aortic dissection, thrombocytopenia.
Management: 1:1 counterpulsation triggered by ECG or arterial pressure waveform.
Cross-Examination (5 Q&A):
Diagnosis: Transcatheter Edge-to-Edge Repair (TEER).
Pathognomonic Sign: Small metallic clip grasping the mitral valve leaflets.
Clinical Risk: Single Leaflet Device Attachment (SLDA), iatrogenic mitral stenosis.
Management: TEE guidance for precise deployment; monitor transmitral gradients.
Cross-Examination (5 Q&A):
Diagnosis: Mechanical Prosthetic Valve.
Pathognomonic Sign: Distinct radiopaque structures: Ball-and-cage (Starr-Edwards), single-tilting disk (Medtronic Hall), or bi-leaflet (St. Jude).
Clinical Risk: Valve thrombosis, major bleeding (from anticoagulation), hemolysis.
Management: Lifelong anticoagulation with Vitamin K Antagonist (Warfarin).
Cross-Examination (5 Q&A):
Diagnosis: TAVR.
Pathognomonic Sign: Large, expandable metallic stent frame housing a bioprosthetic valve in the aortic position.
Clinical Risk: Complete heart block, paravalvular leak, stroke, annular rupture.
Management: Antiplatelet therapy; monitor ECG for PR prolongation or LBBB.
Cross-Examination (5 Q&A):
Diagnosis: Central Venous Catheter (CVC).
Pathognomonic Sign: Radiopaque line with its tip terminating at the cavoatrial junction (where the right heart border meets the SVC).
Clinical Risk: Pneumothorax during insertion, CLABSI (infection).
Management: CXR to confirm position and exclude pneumothorax before use.
Cross-Examination (5 Q&A):
Diagnosis: Pulmonary Artery Catheter.
Pathognomonic Sign: Catheter traversing the RA, RV, and terminating in the proximal Right or LPA.
Clinical Risk: PA rupture, pulmonary infarction (if left wedged).
Management: Ensure balloon is deflated when not actively measuring PCWP.
Cross-Examination (5 Q&A):
Diagnosis: Malpositioned PA Catheter.
Pathognomonic Sign: Catheter tip curled or terminating in the Right Ventricular shadow.
Clinical Risk: Ventricular Tachycardia (VT), Premature Ventricular Contractions (PVCs), RV perforation.
Management: Immediately deflate balloon (if inflated) and either advance to PA or withdraw to RA.
Cross-Examination (5 Q&A):
Diagnosis: ETT Placement.
Pathognomonic Sign: Radiopaque line of the tube terminating 3-5 cm above the carina.
Clinical Risk: Right mainstem intubation, vocal cord injury, hypoxemia.
Management: Auscultate bilaterally; withdraw tube slightly if breath sounds are absent on the left.
Cross-Examination (5 Q&A):
Diagnosis: NGT Placement.
Pathognomonic Sign: Tube coursing below the diaphragm with the tip resting in the gastric bubble.
Clinical Risk: Tracheobronchial intubation, aspiration pneumonia.
Management: CXR confirmation is mandatory before initiating feeds.
Cross-Examination (5 Q&A):
15. Splinter Hemorrhages
Diagnosis: Splinter Hemorrhages (Infective Endocarditis).
Pathognomonic Sign: Linear, dark red-to-brown streaks running longitudinally under the nail bed.
Clinical Risk: Systemic embolization, valvular destruction, mycotic aneurysms.
Management: Obtain three sets of blood cultures, order TEE, start empiric IV antibiotics.
Cross-Examination (5 Q&A):
Q: What is the pathophysiology? A: Microemboli from valvular vegetations lodging in the nail bed capillaries.
Q: Are they specific to Endocarditis? A: No, most commonly caused by local trauma.
Q: What other conditions cause them? A: Vasculitis, antiphospholipid syndrome, trichinosis.
Q: Are they painful? A: Usually painless (unlike Osler's nodes).
Q: Where do they usually appear in endocarditis? A: Distal third of the nail bed.
16. Janeway Lesions
Diagnosis: Janeway Lesions.
Pathognomonic Sign: Painless, erythematous, or hemorrhagic macular lesions on the palms or soles.
Clinical Risk: Acute, highly destructive infective endocarditis.
Management: Urgent blood cultures and echocardiogram for source control.
Cross-Examination (5 Q&A):
Q: Are they painful? A: No, they are strictly painless.
Q: What is the underlying pathology? A: Septic microemboli with microabscess formation in the dermis.
Q: Which organism is classically associated? A: Staphylococcus aureus.
Q: Do they occur in acute or subacute endocarditis? A: Typically acute endocarditis.
Q: Differentiate from Osler's nodes? A: Janeway = Macular, Painless, Palms/Soles. Osler = Nodular, Painful, Finger/Toe pads.
17. Osler's Nodes
Diagnosis: Osler's Nodes.
Pathognomonic Sign: Tender, purplish, raised nodules on the fleshy pads of the fingers or toes.
Clinical Risk: Subacute infective endocarditis (indolent course).
Management: Blood cultures and immune complex workup (e.g., Rheumatoid Factor).
Cross-Examination (5 Q&A):
Q: Are they painful? A: Yes, highly tender.
Q: What is the underlying pathology? A: Immune complex deposition leading to localized vasculitis.
Q: Which organism is classically associated? A: Streptococcus viridans.
Q: Do they contain bacteria? A: Usually sterile (immune-mediated).
Q: What lab marker is often positive with Osler's nodes? A: Rheumatoid Factor (positive in 50% of subacute endocarditis cases).
18. Clubbing
Diagnosis: Digital Clubbing.
Pathognomonic Sign: Bulbous enlargement of the distal phalanges with loss of the normal Lovibond angle (>180°) and obliteration of the Schamroth window.
Clinical Risk: Chronic hypoxia, cyanotic congenital heart disease, endocarditis.
Management: Pulse oximetry, Echo (to rule out R-to-L shunt), and CXR (to rule out lung mass).
Cross-Examination (5 Q&A):
Q: What is the proposed mechanism? A: Megakaryocytes bypass the pulmonary capillary bed (via shunts) and release PDGF and VEGF in the digits, causing fibrovascular proliferation.
Q: Name cyanotic heart defects causing this? A: Tetralogy of Fallot, Eisenmenger syndrome, Transposition of the Great Arteries.
Q: What is the Schamroth window? A: The diamond-shaped gap formed when the dorsal surfaces of terminal phalanges of similar fingers are placed together (absent in clubbing).
Q: Is it reversible? A: Yes, if the underlying cause (e.g., shunt repair) is treated early.
Q: What is differential clubbing? A: Clubbing in the toes but not the fingers (seen in PDA with Eisenmenger syndrome due to post-ductal desaturated blood).
19. Malar Flush
Diagnosis: Mitral Facies (Malar Flush).
Pathognomonic Sign: Plum-red or cyanotic discoloration of the high cheeks.
Clinical Risk: Severe Mitral Stenosis, advanced pulmonary hypertension, low cardiac output.
Management: Echocardiography to evaluate mitral valve area and pulmonary artery pressures.
Cross-Examination (5 Q&A):
Q: What is the pathophysiology? A: Low cardiac output leading to severe peripheral vasoconstriction, combined with CO2 retention causing local vasodilation and blood stagnation in the cheeks.
Q: How do you differentiate this from the butterfly rash of SLE? A: SLE rash spares the nasolabial folds and is an active dermatitis; Malar flush is a vascular phenomenon.
Q: Which valvular disease is classic? A: Rheumatic Mitral Stenosis.
Q: What happens to the extremities? A: They are typically cold and clammy due to the low output state.
Q: Does fixing the valve reverse the flush? A: Yes, if cardiac output and PHTN normalize.
20. Peripheral Cyanosis
Diagnosis: Acrocyanosis (Peripheral Cyanosis).
Pathognomonic Sign: Bluish discoloration of the distal extremities (fingers/toes) while the central mucosa (tongue/lips) remains pink.
Clinical Risk: Cardiogenic shock, severe heart failure, peripheral arterial disease, cold exposure.
Management: Hemodynamic support to improve cardiac output; gentle rewarming.
Cross-Examination (5 Q&A):
Q: What is the key differentiator from central cyanosis? A: The tongue and oral mucosa are normal (pink) in peripheral cyanosis.
Q: What is the mechanism? A: Sluggish capillary blood flow leading to increased oxygen extraction by the tissues.
Q: What level of deoxygenated hemoglobin is required to see cyanosis? A: Greater than 5 g/dL of absolute deoxygenated hemoglobin.
Q: Can a severely anemic patient become cyanotic? A: Rarely, because they cannot generate 5 g/dL of deoxygenated Hb without dying first.
Q: Does applying heat improve peripheral cyanosis? A: Yes, if the cause is cold-induced vasoconstriction, local warming will resolve it.
20 ADDITIONAL PROCEDURES, DEVICES & CLINICAL SIGNS
Diagnosis: Splinter Hemorrhages (Infective Endocarditis).
Pathognomonic Sign: Linear, dark red-to-brown streaks running longitudinally under the nail bed.
Clinical Risk: Systemic embolization, valvular destruction, mycotic aneurysms.
Management: Obtain three sets of blood cultures, order TEE, start empiric IV antibiotics.
Cross-Examination (5 Q&A):
Diagnosis: Janeway Lesions.
Pathognomonic Sign: Painless, erythematous, or hemorrhagic macular lesions on the palms or soles.
Clinical Risk: Acute, highly destructive infective endocarditis.
Management: Urgent blood cultures and echocardiogram for source control.
Cross-Examination (5 Q&A):
Diagnosis: Osler's Nodes.
Pathognomonic Sign: Tender, purplish, raised nodules on the fleshy pads of the fingers or toes.
Clinical Risk: Subacute infective endocarditis (indolent course).
Management: Blood cultures and immune complex workup (e.g., Rheumatoid Factor).
Cross-Examination (5 Q&A):
Diagnosis: Digital Clubbing.
Pathognomonic Sign: Bulbous enlargement of the distal phalanges with loss of the normal Lovibond angle (>180°) and obliteration of the Schamroth window.
Clinical Risk: Chronic hypoxia, cyanotic congenital heart disease, endocarditis.
Management: Pulse oximetry, Echo (to rule out R-to-L shunt), and CXR (to rule out lung mass).
Cross-Examination (5 Q&A):
Diagnosis: Mitral Facies (Malar Flush).
Pathognomonic Sign: Plum-red or cyanotic discoloration of the high cheeks.
Clinical Risk: Severe Mitral Stenosis, advanced pulmonary hypertension, low cardiac output.
Management: Echocardiography to evaluate mitral valve area and pulmonary artery pressures.
Cross-Examination (5 Q&A):
Diagnosis: Acrocyanosis (Peripheral Cyanosis).
Pathognomonic Sign: Bluish discoloration of the distal extremities (fingers/toes) while the central mucosa (tongue/lips) remains pink.
Clinical Risk: Cardiogenic shock, severe heart failure, peripheral arterial disease, cold exposure.
Management: Hemodynamic support to improve cardiac output; gentle rewarming.
Cross-Examination (5 Q&A):
PROCEDURES & DEVICES (FLUOROSCOPY / HARDWARE)
21. Impella Left Ventricular Assist Device
Diagnosis: Impella CP or 5.5.
Pathognomonic Sign: Catheter crossing the aortic valve with the pigtail resting in the LV apex and the inflow/outflow ports straddling the valve.
Clinical Risk: Aortic valve injury, hemolysis, limb ischemia, migration.
Management: Echocardiography to confirm position (inflow 3.5 cm below the aortic annulus).
Cross-Examination (5 Q&A):
Q: How does it work? A: It is a continuous axial flow pump pulling blood from the LV and expelling it into the ascending aorta.
Q: What is the hemodynamic effect on the LV? A: Directly unloads the LV, decreasing LVEDP and myocardial oxygen demand.
Q: What happens if it migrates too deep into the LV? A: The outflow port enters the LV, causing zero forward flow (ineffective support) and potentially damaging mitral chordae.
Q: What happens if it pulls back into the aorta? A: The inflow port sits in the aorta, causing massive hemolysis and loss of support.
Q: Absolute contraindication? A: Moderate to severe Aortic Regurgitation, Mechanical Aortic Valve, or LV thrombus.
22. Watchman Device (LAA Occluder)
Diagnosis: Left Atrial Appendage Occlusion Device (Watchman).
Pathognomonic Sign: Parachute-shaped nitinol frame deployed within the Left Atrial Appendage on fluoroscopy or CXR.
Clinical Risk: Device embolization, pericardial effusion/tamponade, device-related thrombus (DRT).
Management: Dual antiplatelet therapy or short-term oral anticoagulation post-implant until endothelialization is confirmed by TEE at 45 days.
Cross-Examination (5 Q&A):
Q: What is the primary indication? A: Non-valvular Atrial Fibrillation patients with high stroke risk who cannot tolerate long-term anticoagulation.
Q: What are the PASS criteria for deployment? A: Position, Anchor, Size, Seal.
Q: How is it delivered? A: Transseptal puncture (inferior and posterior on the septum).
Q: What imaging guides the procedure? A: Intraprocedural TEE and fluoroscopy.
Q: Complication if sized too small? A: Device embolization into the LV or aorta.
23. Coronary Angiogram: "Spider View"
Diagnosis: Left Main Coronary Artery Bifurcation (LAO Caudal view).
Pathognomonic Sign: Foreshortened Left Main dividing into the LAD (coursing upwards/right) and LCx (coursing downwards/left).
Clinical Risk: Missed ostial or bifurcation disease if not carefully evaluated.
Management: Assess for PCI or CABG depending on SYNTAX score.
Cross-Examination (5 Q&A):
Q: What are the typical angles for this view? A: LAO 40-50 degrees, Caudal 20-30 degrees.
Q: Why is it called the Spider view? A: The LM, LAD, LCx, and Ramus Intermedius (if present) resemble the legs of a spider.
Q: What is it best at visualizing? A: The Left Main bifurcation and proximal LCx.
Q: What is its major limitation? A: It severely foreshortens the mid and distal LAD.
Q: If the catheter engages deeply, what is missed? A: Left Main ostial disease.
24. Coronary Angiogram: RAO Cranial View
Diagnosis: LAD and Diagonal branches.
Pathognomonic Sign: The LAD courses straight down the middle of the screen, with septal perforators branching to the left and diagonals to the right.
Clinical Risk: LAD occlusion (anterior STEMI).
Management: Stenting or balloon angioplasty.
Cross-Examination (5 Q&A):
Q: What are the typical angles? A: RAO 20-30 degrees, Cranial 30-40 degrees.
Q: What is this view best for? A: The mid and distal LAD, and the origins of the diagonal branches.
Q: How do you identify septal branches? A: They have a "wire-like", non-tortuous appearance and course straight into the myocardium.
Q: How do you identify the LAD vs the LCx in cranial views? A: The LAD reaches the apex; the LCx remains in the AV groove.
Q: Does this view show the Left Main well? A: No, the Left Main is often foreshortened or obscured by the spine.
25. V-A ECMO Cannulae
Diagnosis: Veno-Arterial Extracorporeal Membrane Oxygenation.
Pathognomonic Sign: Large venous drainage cannula in the right atrium (via femoral vein) and an arterial return cannula in the iliac artery/distal aorta (via femoral artery).
Clinical Risk: LV distension, Harlequin syndrome (North-South syndrome), severe limb ischemia.
Management: Monitor hemodynamics, LV unloading (often requires concurrent IABP or Impella), and distal perfusion catheter for the leg.
Cross-Examination (5 Q&A):
Q: What is the purpose of V-A ECMO? A: Provides both complete respiratory and complete hemodynamic (biventricular) support.
Q: Why does the LV distend? A: Retrograde aortic flow from the arterial cannula increases afterload, preventing the failing LV from opening the aortic valve.
Q: What is Harlequin syndrome? A: In recovering lungs, deoxygenated LV blood supplies the upper body, while oxygenated ECMO blood supplies the lower body (upper body cyanosis).
Q: How do you prevent leg ischemia? A: Antegrade distal perfusion catheter (DPC) placed in the superficial femoral artery.
Q: Difference from V-V ECMO? A: V-V ECMO only provides respiratory support (does not bypass the heart).
26. Implantable Loop Recorder (ILR)
Diagnosis: ILR.
Pathognomonic Sign: Small, thin, rectangular radiopaque object resembling a USB drive implanted subcutaneously over the left chest.
Clinical Risk: Missed arrhythmias if sensing is poor; infection.
Management: Remote monitoring for atrial fibrillation, pauses, or tachycardia.
Cross-Examination (5 Q&A):
Q: What is the battery life? A: Typically 3 to 4 years.
Q: What is the primary indication? A: Unexplained syncope (cryptogenic) or cryptogenic stroke (to look for silent AFib).
Q: Are there intravascular leads? A: No, it is purely subcutaneous.
Q: How is data captured? A: Automatically based on programmed parameters, or manually by the patient using an activator during symptoms.
Q: Is it MRI safe? A: Yes, modern ILRs are MRI conditional.
27. Melody Valve (Transcatheter Pulmonary Valve)
Diagnosis: Transcatheter Pulmonary Valve Replacement.
Pathognomonic Sign: Bovine jugular vein valve sutured within a platinum-iridium stent, deployed in the pulmonary position.
Clinical Risk: Stent fracture, endocarditis, coronary artery compression during deployment.
Management: Serial echocardiography to monitor gradients and RV function.
Cross-Examination (5 Q&A):
Q: What is the most common indication? A: Dysfunctional Right Ventricle-to-Pulmonary Artery (RV-PA) conduit in repaired Tetralogy of Fallot.
Q: What is a major pre-procedural risk assessment? A: Coronary compression testing (balloon sizing in the conduit while performing coronary angiography).
Q: Which coronary is most at risk? A: The Left Anterior Descending (LAD) artery, especially if it has an anomalous course.
Q: What complication is the Melody valve particularly prone to compared to surgical valves? A: Infective endocarditis.
Q: How do you prevent stent fracture? A: Pre-stenting the conduit with bare metal stents before deploying the valve.
CLINICAL SIGNS & SYNDROMES (OSCE PHOTOS)
Diagnosis: Impella CP or 5.5.
Pathognomonic Sign: Catheter crossing the aortic valve with the pigtail resting in the LV apex and the inflow/outflow ports straddling the valve.
Clinical Risk: Aortic valve injury, hemolysis, limb ischemia, migration.
Management: Echocardiography to confirm position (inflow 3.5 cm below the aortic annulus).
Cross-Examination (5 Q&A):
Diagnosis: Left Atrial Appendage Occlusion Device (Watchman).
Pathognomonic Sign: Parachute-shaped nitinol frame deployed within the Left Atrial Appendage on fluoroscopy or CXR.
Clinical Risk: Device embolization, pericardial effusion/tamponade, device-related thrombus (DRT).
Management: Dual antiplatelet therapy or short-term oral anticoagulation post-implant until endothelialization is confirmed by TEE at 45 days.
Cross-Examination (5 Q&A):
Diagnosis: Left Main Coronary Artery Bifurcation (LAO Caudal view).
Pathognomonic Sign: Foreshortened Left Main dividing into the LAD (coursing upwards/right) and LCx (coursing downwards/left).
Clinical Risk: Missed ostial or bifurcation disease if not carefully evaluated.
Management: Assess for PCI or CABG depending on SYNTAX score.
Cross-Examination (5 Q&A):
Diagnosis: LAD and Diagonal branches.
Pathognomonic Sign: The LAD courses straight down the middle of the screen, with septal perforators branching to the left and diagonals to the right.
Clinical Risk: LAD occlusion (anterior STEMI).
Management: Stenting or balloon angioplasty.
Cross-Examination (5 Q&A):
Diagnosis: Veno-Arterial Extracorporeal Membrane Oxygenation.
Pathognomonic Sign: Large venous drainage cannula in the right atrium (via femoral vein) and an arterial return cannula in the iliac artery/distal aorta (via femoral artery).
Clinical Risk: LV distension, Harlequin syndrome (North-South syndrome), severe limb ischemia.
Management: Monitor hemodynamics, LV unloading (often requires concurrent IABP or Impella), and distal perfusion catheter for the leg.
Cross-Examination (5 Q&A):
Diagnosis: ILR.
Pathognomonic Sign: Small, thin, rectangular radiopaque object resembling a USB drive implanted subcutaneously over the left chest.
Clinical Risk: Missed arrhythmias if sensing is poor; infection.
Management: Remote monitoring for atrial fibrillation, pauses, or tachycardia.
Cross-Examination (5 Q&A):
Diagnosis: Transcatheter Pulmonary Valve Replacement.
Pathognomonic Sign: Bovine jugular vein valve sutured within a platinum-iridium stent, deployed in the pulmonary position.
Clinical Risk: Stent fracture, endocarditis, coronary artery compression during deployment.
Management: Serial echocardiography to monitor gradients and RV function.
Cross-Examination (5 Q&A):
28. Tendon Xanthomas
Diagnosis: Familial Hypercholesterolemia (Heterozygous or Homozygous).
Pathognomonic Sign: Nodular swelling and thickening of the Achilles tendons or extensor tendons of the hands.
Clinical Risk: Premature severe coronary artery disease (often before age 40).
Management: High-intensity statins, Ezetimibe, PCSK9 inhibitors.
Cross-Examination (5 Q&A):
Q: What is the underlying defect? A: Mutation in the LDL receptor, ApoB, or PCSK9 gene.
Q: Are these painful? A: Usually painless, though they can cause mechanical irritation.
Q: What do they consist of? A: Cholesterol deposits engulfed by macrophages (foam cells).
Q: Can they regress with treatment? A: Yes, aggressive lipid-lowering can cause regression over years.
Q: Differentiate from eruptive xanthomas? A: Eruptive xanthomas are small red/yellow papules on buttocks/extensor surfaces caused by severe hypertriglyceridemia, not high LDL.
29. Corneal Arcus (Arcus Juvenilis)
Diagnosis: Premature Corneal Arcus.
Pathognomonic Sign: Gray/white opaque ring around the peripheral cornea in a patient under 45 years old.
Clinical Risk: Strongly associated with severe dyslipidemia and premature CAD.
Management: Fasting lipid profile and aggressive lipid management.
Cross-Examination (5 Q&A):
Q: Is it specific for CAD in the elderly? A: No, arcus senilis is common and benign in the elderly (over 60).
Q: What is the ring composed of? A: Extracellular lipid (cholesterol and phospholipids) deposited in the corneal stroma.
Q: Does it affect vision? A: No, it never encroaches on the visual axis.
Q: If seen unilaterally, what does it signify? A: Carotid artery stenosis on the side without the arcus (the arcus side has normal blood flow delivering the lipids).
Q: Does it disappear with statin therapy? A: No, it is permanent once formed.
30. Frank's Sign
Diagnosis: Diagonal Earlobe Crease.
Pathognomonic Sign: Deep, diagonal crease extending from the tragus across the lobule of the ear.
Clinical Risk: Epidemiological marker for underlying Coronary Artery Disease.
Management: Cardiovascular risk stratification (stress test or CCTA if symptomatic).
Cross-Examination (5 Q&A):
Q: Is it highly sensitive or specific? A: Neither, but it has a statistically significant correlation with CAD.
Q: What is the proposed mechanism? A: Loss of dermal elastin and vascular supply, mirroring similar microvascular changes in the coronary bed.
Q: Is it more predictive in young or old patients? A: More predictive in younger patients (<60 years).
Q: Does it require immediate intervention? A: No, it is merely a physical sign prompting a deeper cardiovascular workup.
Q: Are bilateral creases worse than unilateral? A: Yes, bilateral deep creases carry a higher correlation with CAD severity.
31. Quincke's Pulse
Diagnosis: Severe Aortic Regurgitation (Chronic).
Pathognomonic Sign: Visible capillary pulsation (alternating blanching and flushing) in the nail bed when gentle pressure is applied to the tip of the nail.
Clinical Risk: Left ventricular volume overload, eventual heart failure.
Management: Echocardiography to assess LV size and surgical timing.
Cross-Examination (5 Q&A):
Q: What causes all peripheral signs of AR? A: A massive stroke volume combined with rapid diastolic runoff back into the LV (wide pulse pressure).
Q: Can this be seen elsewhere? A: Yes, in the lips when pressed with a glass slide.
Q: Is it present in acute AR? A: No, acute AR has a narrow pulse pressure because the LV has not dilated yet.
Q: What is the difference between Quincke's and Corrigan's pulse? A: Quincke's is capillary; Corrigan's is the rapidly rising and collapsing carotid artery pulse.
Q: What happens to the diastolic blood pressure? A: It becomes extremely low, often approaching zero.
32. Corrigan's Pulse / Water-Hammer Pulse
Diagnosis: Severe Aortic Regurgitation.
Pathognomonic Sign: Bounding, forceful pulse with a rapid upstroke and rapid collapse (best felt at the radial or carotid artery).
Clinical Risk: LV dysfunction.
Management: Valve replacement when LV EF drops < 50% or LVESD > 50mm.
Cross-Examination (5 Q&A):
Q: How is the radial water-hammer pulse best elicited? A: Grasp the patient's forearm and raise their arm rapidly above their head to accentuate the rapid runoff.
Q: What is a pistol-shot sound (Traube's sign)? A: Booming systolic and diastolic sounds heard over the femoral artery.
Q: What is Duroziez's sign? A: Systolic and diastolic murmurs heard over the femoral artery when compressed by a stethoscope.
Q: Does a fast heart rate worsen or improve AR? A: Tachycardia improves AR by shortening diastole, reducing the time for regurgitation.
Q: What is the classic murmur? A: Early diastolic, high-pitched decrescendo murmur at the left sternal border.
33. De Musset's Sign
Diagnosis: Severe Aortic Regurgitation.
Pathognomonic Sign: Rhythmic nodding or bobbing of the head in synchrony with the heartbeat.
Clinical Risk: Correlates with large stroke volumes and severe AR.
Management: Aortic valve surgery workup.
Cross-Examination (5 Q&A):
Q: Who is the sign named after? A: Alfred de Musset, a French poet who had syphilitic aortitis.
Q: Why does the head bob? A: The massive stroke volume causes ballistic forces to transmit through the carotid arteries.
Q: What is Becker's sign? A: Visible pulsation of the retinal arteries and pupils.
Q: What is Muller's sign? A: Systolic pulsation of the uvula.
Q: Are these signs reliable indicators of LV function? A: No, they only indicate wide pulse pressure; the LV may be failing despite these signs.
34. Kussmaul's Sign
Diagnosis: Constrictive Pericarditis, Right Ventricular Infarction, or Restrictive Cardiomyopathy.
Pathognomonic Sign: A paradoxical increase (or lack of the normal fall) in the Jugular Venous Pressure (JVP) during inspiration.
Clinical Risk: Severe right heart failure, low cardiac output.
Management: Echo and Right Heart Cath; Pericardiectomy if constrictive.
Cross-Examination (5 Q&A):
Q: What is the normal physiological response? A: JVP should fall during inspiration due to negative intrathoracic pressure drawing blood into the compliant RV.
Q: What is the mechanism of Kussmaul's sign? A: The right heart cannot accommodate the increased venous return due to a rigid pericardium or stiff RV, causing blood to back up into the jugulars.
Q: Is it seen in Cardiac Tamponade? A: NO. This is a critical distinction. Tamponade has a normal inspiratory fall in JVP.
Q: What happens to the JVP 'y' descent in constriction? A: It becomes very rapid and deep (Friedreich's sign).
Q: How do you differentiate constriction from restriction on cath? A: Constriction shows ventricular interdependence; restriction does not.
35. Large 'a' Wave in JVP
Diagnosis: Tricuspid Stenosis, Pulmonary Stenosis, or Right Ventricular Hypertrophy (RVH).
Pathognomonic Sign: A prominent presystolic pulsation in the jugular vein.
Clinical Risk: Right heart failure.
Management: Treat the underlying cause of RV pressure overload.
Cross-Examination (5 Q&A):
Q: What does the 'a' wave represent? A: Atrial contraction against the tricuspid valve.
Q: Why does it become large? A: The RA is contracting against a stiff or obstructed Right Ventricle.
Q: What is a "cannon 'a' wave"? A: A massive pulsation occurring when the RA contracts against a CLOSED tricuspid valve.
Q: When do cannon 'a' waves occur? A: Complete Heart Block, Ventricular Tachycardia, or Junctional rhythm (AV dissociation).
Q: In what rhythm is the 'a' wave completely absent? A: Atrial Fibrillation.
36. Large 'v' Wave in JVP (cv wave)
Diagnosis: Severe Tricuspid Regurgitation.
Pathognomonic Sign: A large, prominent systolic pulsation in the jugular vein that obliterates the normal 'x' descent (creating a merged 'cv' wave).
Clinical Risk: Hepatic congestion, ascites, peripheral edema.
Management: Diuretics, Tricuspid valve repair/replacement.
Cross-Examination (5 Q&A):
Q: What does the normal 'v' wave represent? A: Venous filling of the RA during ventricular systole (while the tricuspid valve is closed).
Q: Why does it become large in TR? A: The RV ejects blood backwards through the incompetent tricuspid valve directly into the RA and jugular veins.
Q: What physical exam sign accompanies this in the abdomen? A: Pulsatile hepatomegaly.
Q: What happens to the 'y' descent? A: It becomes rapid and deep because the engorged RA empties quickly into the RV when the valve opens.
Q: Does inspiration change the murmur? A: Yes, Carvallo's sign (TR murmur gets louder with inspiration).
37. Arachnodactyly & Thumb/Wrist Sign
Diagnosis: Marfan Syndrome.
Pathognomonic Sign: Disproportionately long, spider-like fingers. Thumb sign (Steinberg): entire thumb protrudes beyond the ulnar border when folded in a fist. Wrist sign (Walker-Murdoch): thumb and pinky overlap when grasping the opposite wrist.
Clinical Risk: Aortic root aneurysm, aortic dissection, Mitral Valve Prolapse.
Management: Strict blood pressure control (Beta-blockers/ARBs), serial echocardiography, prophylactic aortic root replacement.
Cross-Examination (5 Q&A):
Q: What is the genetic defect? A: FBN1 gene mutation (Fibrillin-1).
Q: What is the classic ocular finding? A: Ectopia lentis (upward lens subluxation).
Q: At what aortic root dimension is surgery indicated? A: > 50mm, or > 45mm with risk factors (family history of dissection, rapid growth).
Q: What cardiovascular pathology causes the most mortality? A: Type A Aortic Dissection.
Q: Differentiate from Loeys-Dietz syndrome? A: Loeys-Dietz has bifid uvula, hypertelorism, and a much higher risk of rupture at smaller aortic sizes.
38. Webbed Neck & Shield Chest
Diagnosis: Turner Syndrome (45,X).
Pathognomonic Sign: Broad neck with lateral skin folds, low posterior hairline, and a broad chest with widely spaced nipples.
Clinical Risk: Coarctation of the aorta, Bicuspid Aortic Valve (BAV).
Management: Lifelong cardiac screening, hypertension management.
Cross-Examination (5 Q&A):
Q: What is the most common cardiac anomaly? A: Bicuspid Aortic Valve (30%).
Q: What is the most highly associated vascular anomaly? A: Coarctation of the Aorta (10-20%).
Q: What must be checked before a patient with Turner syndrome gets pregnant? A: Aortic root size (extreme risk of dissection during pregnancy).
Q: Are they at risk for aortic dissection without a dilated root? A: Yes, the vascular tissue itself is inherently abnormal.
Q: Is fertility normal? A: No, they suffer from primary amenorrhea and streak ovaries.
39. Down Syndrome Facies
Diagnosis: Trisomy 21 (Down Syndrome).
Pathognomonic Sign: Upward slanting palpebral fissures, epicanthal folds, flat nasal bridge, and macroglossia.
Clinical Risk: Endocardial Cushion Defects (Complete AV Canal).
Management: Early surgical repair of congenital defects to prevent fixed pulmonary hypertension.
Cross-Examination (5 Q&A):
Q: What percentage of Trisomy 21 patients have congenital heart disease? A: Approximately 40-50%.
Q: What is the single most common defect? A: Complete Atrioventricular Septal Defect (AVSD).
Q: Why do they develop Eisenmenger syndrome faster than others? A: Down syndrome patients have inherent lung hypoplasia and upper airway obstruction, accelerating PHTN.
Q: What is the classic ECG finding in AVSD? A: Left Axis Deviation (due to displacement of the AV node).
Q: If they have a VSD, which type is it usually? A: Inlet VSD.
40. Differential Cyanosis
Diagnosis: Patent Ductus Arteriosus (PDA) with Eisenmenger Syndrome.
Pathognomonic Sign: Pink upper extremities (normal oxygenation) and cyanotic, clubbed lower extremities.
Clinical Risk: Right heart failure, paradoxical emboli to the lower body, death.
Management: Palliative care, heart-lung transplantation (defect closure is strictly contraindicated).
Cross-Examination (5 Q&A):
Q: Why is the upper body pink? A: The brachiocephalic, left carotid, and left subclavian arteries branch off the aorta proximal to the ductus arteriosus.
Q: Why is the lower body blue? A: Desaturated blood from the Right Ventricle shunts right-to-left across the PDA into the descending aorta.
Q: What happens if you surgically close the PDA at this stage? A: Acute right heart failure and death, as the PDA acts as a pop-off valve for the suprasystemic pulmonary pressures.
Q: Is the left arm always pink? A: Usually, but if the PDA is large and proximal, the left subclavian may receive mixed blood, causing mild left arm cyanosis compared to the right arm.
Q: What drug class is used for symptom management? A: Pulmonary vasodilators (PDE-5 inhibitors, Endothelin receptor antagonists).
41. Eruptive Xanthomas
Diagnosis: Severe Hypertriglyceridemia (often Type I or V hyperlipidemia).
Pathognomonic Sign: Crops of small, red-yellow papules on an erythematous base, typically on the extensor surfaces of arms, legs, and buttocks.
Clinical Risk: Acute pancreatitis (highest risk), premature CAD.
Management: Fibrates, Omega-3 fatty acids, strict glycemic control, and dietary fat restriction.
Cross-Examination (5 Q&A):
Q: At what triglyceride level do these typically appear? A: Usually when triglycerides exceed 1000 mg/dL.
Q: Are they permanent? A: No, they resolve rapidly (weeks to months) when triglyceride levels are lowered.
Q: What is the underlying pathophysiology? A: Chylomicrons and VLDL extravasating into the dermis, engulfed by macrophages.
Q: What fundoscopic finding often accompanies this? A: Lipemia retinalis (milky-white appearance of retinal vessels).
Q: Does statin monotherapy resolve this? A: No, statins weakly lower triglycerides; fibrates or niacin are required.
42. Xanthelasma Palpebrarum
Diagnosis: Dyslipidemia (often familial, though 50% have normal lipids).
Pathognomonic Sign: Soft, yellowish, cholesterol-filled plaques on the medial aspects of the eyelids.
Clinical Risk: Independent risk marker for Coronary Artery Disease and myocardial infarction.
Management: Complete lipid profile assessment and CAD risk stratification.
Cross-Examination (5 Q&A):
Q: Does their presence guarantee hypercholesterolemia? A: No, up to half of patients have normal plasma lipid levels.
Q: What are the plaques composed of? A: Intradermal collections of cholesterol-laden macrophages (foam cells).
Q: If seen in a patient under 40, what must be ruled out? A: Familial Hypercholesterolemia (FH).
Q: Do they regress with statin therapy? A: Rarely; they usually require surgical excision or laser ablation if cosmetically bothersome.
Q: What liver condition is classically associated? A: Primary Biliary Cholangitis (PBC).
43. Roth Spots (Fundoscopy)
Diagnosis: Infective Endocarditis.
Pathognomonic Sign: Retinal hemorrhages with pale, white/yellow centers seen on fundoscopic exam.
Clinical Risk: Systemic embolization, severe valvular destruction.
Management: Blood cultures, TEE, IV antibiotics.
Cross-Examination (5 Q&A):
Q: What constitutes the pale center? A: Fibrin-platelet plugs (immune complex deposition).
Q: Are they pathognomonic exclusively for endocarditis? A: No.
Q: What other conditions cause them? A: Leukemia, severe anemia, systemic lupus erythematosus (SLE), and diabetic retinopathy.
Q: Do they affect vision? A: Usually asymptomatic unless they involve the macula.
Q: Are they considered a major or minor Duke criterion? A: Minor criterion (immunologic phenomenon).
44. Hollenhorst Plaque (Fundoscopy)
Diagnosis: Carotid Artery Atherosclerosis / Embolic Disease.
Pathognomonic Sign: Small, bright, highly refractile golden-yellow crystals lodged at the bifurcations of retinal arterioles.
Clinical Risk: Amaurosis fugax, Transient Ischemic Attack (TIA), stroke.
Management: Carotid Doppler ultrasound, antiplatelets, high-intensity statin.
Cross-Examination (5 Q&A):
Q: What is the plaque made of? A: Cholesterol emboli.
Q: Where do they most commonly originate? A: Ipsilateral internal carotid artery or aortic arch atheroma.
Q: What is the classic clinical symptom? A: Amaurosis fugax (painless, transient monocular vision loss described as a "descending shade").
Q: How do they differ from calcific emboli? A: Calcific emboli are dull white, non-refractile, and usually originate from the aortic or mitral valve.
Q: Do Hollenhorst plaques typically cause permanent infarction? A: Often they do not, as they can fragment and move distally, unlike fibrin-platelet emboli.
45. Livedo Reticularis
Diagnosis: Atheroembolic Disease (Cholesterol Embolization Syndrome) or Vasculitis.
Pathognomonic Sign: Mottled, purplish, lace-like (reticular) discoloration of the skin, most prominent on the lower extremities.
Clinical Risk: Acute kidney injury, bowel ischemia, limb loss.
Management: Discontinue anticoagulation (if applicable), supportive care, statins.
Cross-Examination (5 Q&A):
Q: What is the classic iatrogenic trigger? A: Recent cardiac catheterization, aortic surgery, or initiation of anticoagulation (which strips protective thrombus off plaques).
Q: What lab finding is classically elevated in atheroembolic disease? A: Eosinophils (eosinophilia) and ESR.
Q: What is the mechanism of the discoloration? A: Vasospasm and occlusion of dermal arterioles, leading to deoxygenated blood pooling in the venous plexuses.
Q: How does warming affect it? A: Physiologic livedo reticularis improves with warming; pathologic livedo (atheroemboli) does not.
Q: Why are anticoagulants contraindicated in cholesterol embolization? A: They prevent plaque healing and promote further showering of cholesterol crystals.
46. Blue Toe Syndrome
Diagnosis: Atheroembolic Disease / Microvascular Thrombosis.
Pathognomonic Sign: Sudden onset of painful, cyanotic, or purpuric toes in the presence of palpable pedal pulses.
Clinical Risk: Tissue necrosis, gangrene.
Management: Avoid anticoagulants, use statins, treat pain, allow demarcation.
Cross-Examination (5 Q&A):
Q: Why are the pedal pulses palpable? A: The emboli (cholesterol crystals) are microvascular (100-200 micrometers), so they occlude digital arterioles while the macrovascular dorsalis pedis artery remains open.
Q: What is the triad of Cholesterol Embolization Syndrome? A: Livedo reticularis/blue toes, acute kidney injury, and eosinophilia.
Q: What is the most definitive diagnostic test? A: Skin or renal biopsy showing needle-shaped cholesterol clefts within vessels.
Q: What happens to the cholesterol crystals during tissue processing? A: They dissolve, leaving characteristic empty "clefts" or "ghosts".
Q: Does embolectomy work? A: No, the emboli are too distal and lodged in the microcirculation.
47. Abdominojugular Reflux (Hepatojugular Reflux)
Diagnosis: Right Ventricular Failure / Elevated Left-Sided Filling Pressures.
Pathognomonic Sign: Sustained elevation of the JVP (greater than 3 cm for >15 seconds) during firm, continuous pressure over the mid-abdomen.
Clinical Risk: Decompensated heart failure.
Management: Intravenous loop diuretics, afterload reduction.
Cross-Examination (5 Q&A):
Q: What is the normal physiological response to this test? A: JVP may rise transiently for 1-2 beats but immediately normalizes as the RV pumps the extra venous return forward.
Q: What does a positive test indicate hemodynamically? A: A non-compliant RV or elevated PCWP > 15 mmHg.
Q: Should the patient hold their breath during the maneuver? A: No, the Valsalva maneuver will falsely elevate the JVP; the patient must breathe normally with mouth open.
Q: Is it specific to right heart failure? A: No, it is heavily correlated with left-sided heart failure causing secondary right-sided pressure elevation.
Q: How much pressure should be applied? A: Approximately 20-35 mmHg of pressure for 15-30 seconds.
48. Pectus Excavatum
Diagnosis: Marfan Syndrome or Mitral Valve Prolapse.
Pathognomonic Sign: Caved-in or sunken appearance of the chest (funnel chest).
Clinical Risk: Right heart compression (if severe), aortic root dilation (if Marfan).
Management: Echo to rule out MVP and measure aortic root; surgical Nuss procedure if cardiopulmonary compromise exists.
Cross-Examination (5 Q&A):
Q: What is the most common cardiac valve abnormality associated with this? A: Mitral Valve Prolapse (MVP).
Q: How does severe pectus excavatum affect the ECG? A: Can cause right axis deviation, incomplete RBBB, and negative P waves in V1 (due to cardiac displacement).
Q: How does it affect echocardiography? A: It compresses the RV, falsely mimicking RV volume overload or making parasternal views technically difficult.
Q: Name another genetic syndrome associated with this besides Marfan? A: Loeys-Dietz or Ehlers-Danlos syndrome.
Q: How is severity quantified? A: The Haller Index on CT (transverse diameter divided by AP diameter; >3.2 is severe).
49. Williams Syndrome Facies
Diagnosis: Williams-Beuren Syndrome.
Pathognomonic Sign: "Elfin" facies (broad forehead, short nose with broad tip, full cheeks, wide mouth with full lips).
Clinical Risk: Supravalvular Aortic Stenosis (SVAS), peripheral pulmonary stenosis, sudden cardiac death.
Management: Surgical repair of SVAS; monitor calcium levels.
Cross-Examination (5 Q&A):
Q: What is the genetic deletion? A: Microdeletion on chromosome 7q11.23.
Q: Which specific gene loss causes the vascular anomalies? A: The Elastin (ELN) gene.
Q: What characterizes Supravalvular Aortic Stenosis on Echo? A: Hourglass deformity of the ascending aorta just above the sinotubular junction.
Q: What metabolic abnormality is classic in infancy? A: Idiopathic hypercalcemia.
Q: How are their coronary arteries affected? A: The SVAS restricts flow, and the thickened aortic media can obstruct coronary ostia, leading to ischemia.
50. Noonan Syndrome
Diagnosis: Noonan Syndrome.
Pathognomonic Sign: Webbed neck, short stature, low-set ears, hypertelorism, and ptosis (often called "Male Turner syndrome," though it affects both sexes).
Clinical Risk: Dysplastic Pulmonary Valve Stenosis, Hypertrophic Cardiomyopathy (HCM).
Management: Balloon valvuloplasty (though less effective than in typical PS) or surgical valve replacement.
Cross-Examination (5 Q&A):
Q: What is the most common cardiac defect? A: Pulmonary Valve Stenosis (50% of cases).
Q: How does the pulmonary valve morphology differ from typical congenital PS? A: The leaflets are severely thickened and dysplastic, making balloon valvuloplasty frequently unsuccessful.
Q: What is the second most common cardiac manifestation? A: Hypertrophic Cardiomyopathy (20-30%).
Q: What is the inheritance pattern? A: Autosomal dominant (often mutations in the PTPN11 gene).
Q: Does Noonan syndrome have a normal karyotype? A: Yes (46,XX or 46,XY), unlike Turner syndrome (45,X).
51. Holt-Oram Syndrome
Diagnosis: Holt-Oram Syndrome (Heart-Hand Syndrome).
Pathognomonic Sign: Upper limb abnormalities (absent, hypoplastic, or triphalangeal thumbs) paired with congenital heart disease.
Clinical Risk: Right heart volume overload, heart block.
Management: Surgical/device closure of septal defects, Holter monitor for AV block.
Cross-Examination (5 Q&A):
Q: What is the most common cardiac defect? A: Ostium Secundum ASD.
Q: Are the limb anomalies bilateral or unilateral? A: Can be either, but usually more severe on the left side.
Q: What is the genetic mutation? A: TBX5 gene mutation (Autosomal Dominant).
Q: Can this syndrome cause complete heart block? A: Yes, conduction system disease is a hallmark, even without a structural defect.
Q: Do lower limb anomalies occur in Holt-Oram? A: No, it strictly involves the upper extremities (radial ray anomalies).
52. DiGeorge Syndrome (22q11.2 Deletion)
Diagnosis: DiGeorge Syndrome (CATCH-22).
Pathognomonic Sign: Cleft palate, micrognathia, low-set ears, tubular nose.
Clinical Risk: Conotruncal cardiac anomalies, severe hypocalcemia, immunodeficiency.
Management: Complex surgical repair of outflow tracts, calcium supplementation.
Cross-Examination (5 Q&A):
Q: What does CATCH-22 stand for? A: Cardiac defects, Abnormal facies, Thymic hypoplasia, Cleft palate, Hypocalcemia (chromosome 22).
Q: What class of cardiac defects is almost exclusive to this syndrome? A: Conotruncal anomalies (Truncus Arteriosus, Tetralogy of Fallot, Interrupted Aortic Arch).
Q: Which specific aortic arch anomaly is highly prevalent? A: Interrupted Aortic Arch Type B.
Q: Why do they get hypocalcemia? A: Aplasia or hypoplasia of the parathyroid glands.
Q: Why are irradiated blood products required for transfusion? A: T-cell deficiency (thymic aplasia) puts them at risk for Transfusion-Associated Graft-Versus-Host Disease.
53. Loeys-Dietz Syndrome
Diagnosis: Loeys-Dietz Syndrome.
Pathognomonic Sign: Bifid uvula, cleft palate, hypertelorism, and generalized arterial tortuosity.
Clinical Risk: Highly aggressive aortic and arterial aneurysms/dissections at a young age.
Management: Early prophylactic aortic root replacement (at smaller diameters than Marfan).
Cross-Examination (5 Q&A):
Q: What is the genetic mutation? A: TGFBR1 or TGFBR2 (Transforming Growth Factor Beta Receptor).
Q: How does the aneurysm risk compare to Marfan syndrome? A: Much more aggressive; dissection occurs at smaller aortic diameters and younger ages.
Q: At what aortic root diameter is surgery indicated? A: > 40mm (or > 4.0 cm), depending on the specific mutation variant.
Q: Are aneurysms restricted to the aortic root? A: No, they occur throughout the arterial tree (cerebral, mesenteric, etc.), requiring head-to-pelvis MRA screening.
Q: What skin finding differentiates it from Marfan? A: Translucent skin with easily visible veins and easy bruising (similar to Ehlers-Danlos).
54. Ehlers-Danlos Syndrome (Type IV - Vascular)
Diagnosis: Vascular Ehlers-Danlos Syndrome.
Pathognomonic Sign: Thin, translucent skin, prominent venous pattern, characteristic facial appearance (thin lips, small chin, pinched nose).
Clinical Risk: Spontaneous rupture of arteries (aorta, coronaries), bowel, or gravid uterus.
Management: Strict blood pressure control, avoidance of invasive vascular procedures (extreme risk of vessel tearing).
Cross-Examination (5 Q&A):
Q: What is the genetic mutation? A: COL3A1 gene (Type III collagen defect).
Q: Is joint hypermobility a major feature of the vascular type? A: No, it is usually restricted to the small joints of the hands, unlike classical EDS.
Q: Why are diagnostic angiograms contraindicated? A: The catheters frequently cause fatal arterial dissection or rupture of the friable vessels.
Q: What is a classic non-cardiac cause of sudden death in these patients? A: Spontaneous colonic rupture.
Q: If cardiac surgery is mandatory, what is the major technical challenge? A: Sutures tear through the tissue ("like sewing wet tissue paper").
55. Pseudoxanthoma Elasticum (PXE)
Diagnosis: PXE.
Pathognomonic Sign: "Plucked chicken" skin appearance (yellowish papules coalescing into plaques on the neck and flexural creases).
Clinical Risk: Premature coronary artery disease, claudication, restrictive cardiomyopathy.
Management: Risk factor modification, anti-VEGF for ocular complications.
Cross-Examination (5 Q&A):
Q: What is the underlying pathology? A: Fragmentation and progressive calcification of elastic fibers in the skin, eyes, and cardiovascular system.
Q: What is the classic fundoscopic finding? A: Angioid streaks (breaks in Bruch's membrane).
Q: How are the peripheral arteries affected? A: Early and severe calcification leading to claudication in very young patients.
Q: How does it affect the myocardium? A: Endocardial calcification can lead to a restrictive cardiomyopathy pattern.
Q: Inheritance pattern? A: Autosomal recessive (ABCC6 mutation).
56. Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu)
Diagnosis: HHT.
Pathognomonic Sign: Multiple pinpoint telangiectasias on the lips, tongue, face, and fingers.
Clinical Risk: Pulmonary Arteriovenous Malformations (PAVMs), severe epistaxis, high-output heart failure.
Management: Transcatheter embolization of PAVMs, iron replacement.
Cross-Examination (5 Q&A):
Q: Why do these patients get high-output heart failure? A: Massive shunting of blood through hepatic and pulmonary AVMs lowers systemic vascular resistance.
Q: What is the classic presentation of a PAVM? A: Cyanosis, clubbing, and paradoxical brain abscesses.
Q: Does the cyanosis correct with 100% oxygen? A: No, because it is an anatomic right-to-left shunt.
Q: What GI complication leads to severe anemia? A: Bleeding from gastrointestinal telangiectasias.
Q: What is the inheritance pattern? A: Autosomal dominant.
57. Raccoon Eyes (Periorbital Purpura)
Diagnosis: Primary (AL) Amyloidosis.
Pathognomonic Sign: Purpura/ecchymosis around the eyes, especially after minor trauma, coughing, or Valsalva (Pinch purpura).
Clinical Risk: Restrictive cardiomyopathy, severe arrhythmias, rapidly progressive heart failure.
Management: Bone marrow biopsy, chemotherapy, autologous stem cell transplant.
Cross-Examination (5 Q&A):
Q: Why does the purpura occur? A: Amyloid infiltration of the dermal blood vessels makes them extremely fragile.
Q: What happens to the ECG voltages? A: Low QRS voltages in limb leads, in stark contrast to the thickened walls seen on Echo.
Q: Is this sign seen in ATTR (Transthyretin) Amyloidosis? A: No, periorbital purpura is highly specific for AL (Light Chain) amyloidosis.
Q: What is the classic finding on right heart catheterization? A: "Square root" sign (dip and plateau) in the ventricular diastolic pressure tracing.
Q: What medication class is notoriously toxic in these patients? A: Digoxin and Calcium Channel Blockers (they bind tightly to amyloid fibrils causing severe toxicity).
58. Macroglossia
Diagnosis: Primary (AL) Amyloidosis.
Pathognomonic Sign: Massively enlarged, firm, easily indentable tongue (often with tooth indentations on the lateral borders).
Clinical Risk: Airway obstruction, restrictive heart failure.
Management: Tissue biopsy (fat pad or tongue) with Congo Red staining.
Cross-Examination (5 Q&A):
Q: What color does the biopsy turn under polarized light? A: Apple-green birefringence.
Q: Is macroglossia seen in ATTR amyloidosis? A: Extremely rare; like raccoon eyes, it is a hallmark of AL amyloid.
Q: How does cardiac amyloid affect the atria? A: Causes massive bi-atrial enlargement, leading to a high risk of Atrial Fibrillation and intra-atrial thrombus.
Q: What Echo sign is seen in the myocardium? A: "Sparkling" or granular texture.
Q: Why is survival so poor in AL compared to ATTR? A: The circulating light chains are directly toxic to cardiomyocytes, accelerating apoptosis independent of the physical infiltration.
59. Carcinoid Flushing
Diagnosis: Carcinoid Syndrome.
Pathognomonic Sign: Episodic, bright red flushing of the face, neck, and upper chest, often accompanied by wheezing and diarrhea.
Clinical Risk: Severe Right Heart Failure (Tricuspid Regurgitation / Pulmonary Stenosis).
Management: Somatostatin analogs (Octreotide), valve replacement surgery.
Cross-Examination (5 Q&A):
Q: What vasoactive substance causes the flushing and cardiac damage? A: Serotonin (5-HT).
Q: For GI carcinoid tumors to cause cardiac syndrome, what must occur? A: The tumor must metastasize to the liver (bypassing hepatic degradation of serotonin).
Q: Why is the left heart usually spared? A: Monoamine oxidase in the pulmonary vascular bed destroys the serotonin before it reaches the left heart.
Q: What are the characteristic valvular lesions? A: Thickened, retracted, and fixed leaflets causing severe TR and PS.
Q: What biomarker is tested in the urine? A: 24-hour urine 5-HIAA.
60. Tuberous Sclerosis Skin Lesions
Diagnosis: Tuberous Sclerosis Complex (TSC).
Pathognomonic Sign: Facial angiofibromas (adenoma sebaceum), ash-leaf spots (hypomelanotic macules), and Shagreen patches.
Clinical Risk: Cardiac Rhabdomyoma leading to outflow tract obstruction or arrhythmias in infancy.
Management: Observation (tumors usually regress), mTOR inhibitors (Everolimus) if obstructive.
Cross-Examination (5 Q&A):
Q: What is the most common pediatric cardiac tumor? A: Rhabdomyoma.
Q: Do these tumors typically require surgery? A: No, they spontaneously regress in size as the child grows.
Q: What is the genetic mutation? A: TSC1 (Hamartin) or TSC2 (Tuberin).
Q: Where are the cardiac tumors usually located? A: Ventricular myocardium or septum, often multiple.
Q: How do you highlight ash-leaf spots on a physical exam? A: Using a Wood's lamp (UV light).
61. Neonatal Lupus Erythematosus
Diagnosis: Congenital Complete Heart Block.
Pathognomonic Sign: Annular erythematous plaques on the scalp/face of a neonate, accompanied by profound bradycardia.
Clinical Risk: Permanent Complete Heart Block, heart failure (hydrops fetalis).
Management: Permanent epicardial pacemaker implantation in the neonate.
Cross-Examination (5 Q&A):
Q: Which maternal antibodies cross the placenta to cause this? A: Anti-Ro (SSA) and Anti-La (SSB) antibodies.
Q: What does the antibody do to the fetal heart? A: Causes autoimmune inflammation and permanent fibrosis of the AV node.
Q: Is the maternal lupus usually symptomatic? A: Often the mother is completely asymptomatic at the time of delivery.
Q: Does the heart block resolve when maternal antibodies clear? A: No, the AV node destruction is irreversible.
Q: Do the skin lesions resolve? A: Yes, the rash typically disappears by 6 months of age as maternal antibodies degrade.
62. Ankylosing Spondylitis Posture
Diagnosis: Ankylosing Spondylitis.
Pathognomonic Sign: "Question mark" posture (exaggerated thoracic kyphosis, loss of lumbar lordosis) and fixed neck flexion.
Clinical Risk: Aortitis, severe Aortic Regurgitation, AV block.
Management: Echocardiography, aortic valve replacement if indicated, permanent pacing for block.
Cross-Examination (5 Q&A):
Q: What is the genetic marker strongly associated with this? A: HLA-B27.
Q: What is the mechanism of Aortic Regurgitation? A: Inflammation and fibrosis of the aortic root leading to dilation and retraction of the aortic cusps.
Q: Does the aortitis involve the entire aorta? A: Usually limited to the ascending aorta and aortic root.
Q: Why does AV block occur? A: The fibrotic process extends directly from the aortic valve down into the adjacent interventricular septum/His bundle.
Q: What is the classic X-ray finding in the spine? A: Bamboo spine (syndesmophytes bridging the intervertebral discs).
63. Pectus Carinatum
Diagnosis: Marfan Syndrome (or severe childhood asthma).
Pathognomonic Sign: Outward protrusion of the sternum and ribs ("pigeon chest").
Clinical Risk: Aortic root dilation, MVP.
Management: Echocardiography for aortic root dimensions.
Cross-Examination (5 Q&A):
Q: Is Pectus Carinatum or Pectus Excavatum more specific for Marfan syndrome? A: Pectus Carinatum is highly specific for Marfan, whereas Excavatum is seen in many conditions.
Q: What is the Ghent nosology? A: Diagnostic criteria for Marfan syndrome integrating clinical signs and family history.
Q: What defines an enlarged aortic root in Marfan? A: Z-score > 2.0.
Q: Does Pectus Carinatum restrict lung capacity like Excavatum? A: No, it causes increased AP diameter and less cardiopulmonary restriction.
Q: What medication slows the progression of aortic dilation? A: Losartan (ARB) or Beta-blockers.
64. Neonatal Lymphedema (Pedal Edema)
Diagnosis: Turner Syndrome (45,X).
Pathognomonic Sign: Puffy, swollen hands and feet in a newborn female.
Clinical Risk: Coarctation of the aorta, Bicuspid Aortic Valve.
Management: 4-limb blood pressures, Echocardiogram.
Cross-Examination (5 Q&A):
Q: What causes the lymphedema? A: Congenital dysplasia of the lymphatic system.
Q: What is a cystic hygroma? A: A massive lymphatic malformation on the neck, common in Turner fetuses, leading to the webbed neck phenotype postnatally.
Q: What is the classic pulse finding in Coarctation? A: Radio-femoral delay with weak/absent femoral pulses.
Q: In a Turner patient, what is the target BP goal? A: Strict normalization, as hypertension dramatically increases the risk of aortic dissection.
Q: What is the typical Echo gradient across a severe coarctation? A: > 20 mmHg peak-to-peak gradient, often with diastolic runoff (sawtooth pattern).
65. Pes Cavus & Kyphoscoliosis
Diagnosis: Friedreich's Ataxia.
Pathognomonic Sign: Unusually high arches of the feet (pes cavus), hammer toes, and progressive spinal curvature.
Clinical Risk: Concentric Hypertrophic Cardiomyopathy, heart failure, arrhythmias.
Management: Echocardiogram, symptom management (no cure).
Cross-Examination (5 Q&A):
Q: What is the genetic mutation? A: GAA trinucleotide repeat expansion in the FXN (Frataxin) gene.
Q: How does the cardiac hypertrophy differ from sarcomeric HCM? A: It is usually concentric and symmetric, unlike the asymmetric septal hypertrophy of classic HCM.
Q: Is LVOT obstruction common? A: No, because the hypertrophy is concentric.
Q: What is the most common cause of death in these patients? A: Cardiac dysfunction (heart failure or fatal arrhythmias).
Q: What endocrine abnormality frequently accompanies this? A: Diabetes Mellitus.
66. Erythema Marginatum
Diagnosis: Acute Rheumatic Fever (ARF).
Pathognomonic Sign: Non-pruritic, pink, macular rings with central clearing and serpiginous spreading margins, primarily on the trunk and proximal limbs (sparing the face).
Clinical Risk: Severe pancarditis, leading to chronic rheumatic heart disease (MS, MR, AS, AR).
Management: Penicillin G (eradication of Strep), high-dose aspirin (polyarthritis), and corticosteroids (severe carditis).
Cross-Examination (5 Q&A):
Q: Is it a major or minor Jones criterion? A: Major criterion.
Q: Does the rash worsen with a specific trigger? A: Yes, it transiently worsens with heat (e.g., a warm bath).
Q: Does it leave a scar? A: No, it fades completely without scarring or hyperpigmentation.
Q: What is the latent period between the pharyngitis and the onset of the rash? A: Typically 1 to 5 weeks.
Q: Can ARF occur after a streptococcal skin infection (impetigo)? A: No, ARF only follows pharyngeal group A strep infections (unlike Post-Streptococcal Glomerulonephritis).
67. Subcutaneous Nodules
Diagnosis: Acute Rheumatic Fever (ARF).
Pathognomonic Sign: Firm, painless, mobile nodules (0.5 to 2.0 cm) located over the extensor surfaces of joints, scalp, and spine.
Clinical Risk: Strongly correlates with the presence of severe rheumatic carditis.
Management: Treat the underlying ARF; nodules resolve spontaneously within weeks.
Cross-Examination (5 Q&A):
Q: Are they major or minor Jones criteria? A: Major criterion.
Q: Are they painful? A: No, they are strictly painless (differentiating them from Osler's nodes or gouty tophi).
Q: What histological lesion do they resemble? A: Aschoff bodies (the classic granulomatous lesion found in rheumatic myocardium).
Q: How long do they typically last? A: Usually 1 to 4 weeks.
Q: Do they occur in the absence of carditis? A: Rarely; their presence almost guarantees significant cardiac involvement.
68. Sydenham Chorea (St. Vitus Dance)
Diagnosis: Acute Rheumatic Fever (Late manifestation).
Pathognomonic Sign: Rapid, irregular, purposeless, and involuntary movements of the limbs and face, accompanied by emotional lability.
Clinical Risk: High incidence of concurrent or subsequent rheumatic mitral valve disease.
Management: Quiet environment, valproic acid or haloperidol if severe; secondary penicillin prophylaxis is mandatory.
Cross-Examination (5 Q&A):
Q: What is the latent period for Chorea? A: Often 1 to 6 months after the streptococcal infection (longest latent period of all ARF signs).
Q: Are acute phase reactants (CRP/ESR) usually elevated when chorea appears? A: No, because of the long latent period, they have usually normalized.
Q: What is the "milkmaid's grip"? A: Irregular, squeezing contractions of the hand when the patient is asked to grip the examiner's fingers.
Q: Does the chorea persist during sleep? A: No, the movements disappear during sleep.
Q: What is the mechanism? A: Molecular mimicry causing autoimmune cross-reactivity with the basal ganglia.
69. Multiple Lentigines (LEOPARD Syndrome)
Diagnosis: LEOPARD Syndrome (Noonan Syndrome with Multiple Lentigines).
Pathognomonic Sign: Thousands of dark brown freckles (lentigines) covering the head, neck, and trunk, appearing in childhood and sparing the mucous membranes.
Clinical Risk: Hypertrophic Cardiomyopathy (HCM) and Dysplastic Pulmonary Stenosis (PS).
Management: Serial echocardiography, beta-blockers for HCM/LVOT obstruction.
Cross-Examination (5 Q&A):
Q: What does the acronym LEOPARD stand for? A: Lentigines, ECG abnormalities, Ocular hypertelorism, Pulmonary stenosis, Abnormal genitalia, Retardation of growth, Deafness.
Q: What is the classic ECG abnormality? A: Conduction defects, typically prolonged PR interval and bundle branch blocks.
Q: How does the HCM in LEOPARD syndrome differ from classic sarcomeric HCM? A: It often involves biventricular hypertrophy.
Q: What is the genetic mutation? A: PTPN11 gene (a RASopathy, similar to Noonan syndrome).
Q: Do the lentigines worsen with sun exposure? A: No, unlike normal freckles, they are independent of sun exposure.
70. Blue Sclera
Diagnosis: Osteogenesis Imperfecta (Type 1).
Pathognomonic Sign: Deep blue or grayish-blue discoloration of the sclera due to thinning of the collagen layer, revealing the underlying uveal tract.
Clinical Risk: Aortic root dilation, aortic regurgitation, and mitral valve prolapse.
Management: Echocardiographic surveillance of the aortic root; bisphosphonates for bone fragility.
Cross-Examination (5 Q&A):
Q: What is the underlying genetic defect? A: Defect in Type I collagen synthesis (COL1A1 or COL1A2 genes).
Q: What is the most common cardiac complication? A: Aortic Regurgitation due to aortic root dilation.
Q: Does the aortic root dissect as frequently as in Marfan syndrome? A: No, dissection is rare, but severe dilation and regurgitation are common.
Q: What non-cardiac surgical risk is critical in these patients? A: Extremely fragile bones, requiring careful patient handling and intubation positioning.
Q: What other physical finding is classic? A: Hearing loss and dentinogenesis imperfecta (translucent, discolored teeth).
71. Bronze Skin Pigmentation
Diagnosis: Hemochromatosis ("Bronze Diabetes").
Pathognomonic Sign: Slate-gray to bronze hyperpigmentation of the skin, most prominent in sun-exposed areas and genitalia.
Clinical Risk: Restrictive Cardiomyopathy initially, progressing to Dilated Cardiomyopathy and refractory arrhythmias.
Management: Phlebotomy, iron chelation (Deferoxamine), and heart failure therapies.
Cross-Examination (5 Q&A):
Q: What is the best imaging modality to diagnose cardiac involvement? A: Cardiac MRI using T2* (T2-star) relaxation times to quantify myocardial iron.
Q: What T2* value indicates severe cardiac iron loading? A: Less than 10 milliseconds.
Q: Which conduction abnormality is most common? A: AV node block and sick sinus syndrome (iron deposits heavily in the AV node).
Q: Can the cardiac dysfunction be reversed? A: Yes, if phlebotomy and chelation are started early before severe fibrosis occurs.
Q: What is the genetic mutation? A: HFE gene mutation (most commonly C282Y).
72. Sclerodactyly & Facial Telangiectasias
Diagnosis: Systemic Sclerosis / CREST Syndrome.
Pathognomonic Sign: Tight, thickened, shiny skin over the fingers (sclerodactyly) preventing full extension, paired with microstomia (small mouth) and facial telangiectasias.
Clinical Risk: Pulmonary Arterial Hypertension (PAH), myocardial fibrosis, and pericardial effusions.
Management: Right Heart Catheterization (RHC) for PAH diagnosis; endothelin receptor antagonists or PDE-5 inhibitors.
Cross-Examination (5 Q&A):
Q: What does CREST stand for? A: Calcinosis, Raynaud's, Esophageal dysmotility, Sclerodactyly, Telangiectasia.
Q: What is the primary cause of cardiac death in these patients? A: Cor pulmonale due to severe Pulmonary Arterial Hypertension (Group 1 PAH).
Q: How does myocardial involvement present? A: Patchy myocardial fibrosis leading to arrhythmias and diastolic dysfunction, often with normal coronaries.
Q: What antibody is specific to the limited (CREST) form? A: Anti-centromere antibody.
Q: What antibody is specific to the diffuse form? A: Anti-Scl-70 (anti-topoisomerase I).
73. Butterfly Rash (Malar Rash)
Diagnosis: Systemic Lupus Erythematosus (SLE).
Pathognomonic Sign: Erythematous, scaling rash across the bridge of the nose and cheeks, classically sparing the nasolabial folds.
Clinical Risk: Libman-Sacks endocarditis, premature CAD, acute pericarditis.
Management: Corticosteroids, hydroxychloroquine, screening echocardiogram.
Cross-Examination (5 Q&A):
Q: What is Libman-Sacks endocarditis? A: Non-bacterial verrucous endocarditis characterized by sterile vegetations.
Q: Where do the vegetations classically form? A: On the ventricular (undersurface) of the mitral valve, as well as the atrial side.
Q: What is the most common cardiac manifestation of SLE? A: Acute pericarditis.
Q: Why do SLE patients get premature CAD? A: Accelerated atherosclerosis due to chronic systemic inflammation and steroid use.
Q: What congenital block is associated with maternal SLE? A: Congenital complete heart block (Anti-Ro/SSA antibodies crossing the placenta).
74. Exophthalmos & Goiter
Diagnosis: Graves' Disease (Severe Thyrotoxicosis).
Pathognomonic Sign: Proptosis (bulging eyes), lid retraction, and a diffusely enlarged thyroid gland, often with a thyroid bruit.
Clinical Risk: High-output heart failure, Atrial Fibrillation.
Management: Beta-blockers (Propranolol) for rate control and symptom relief, antithyroid drugs (Methimazole).
Cross-Examination (5 Q&A):
Q: What is the mechanism of high-output heart failure? A: T3 causes profound peripheral vasodilation, increasing venous return and massively increasing resting cardiac output.
Q: How does thyroid hormone directly affect the heart? A: Upregulates beta-1 adrenergic receptors and myosin heavy chain alpha.
Q: Does cardioversion for AFib work while the patient is thyrotoxic? A: Rarely; maintaining sinus rhythm is very difficult until the euthyroid state is restored.
Q: What happens to the pulse pressure? A: It widens (high systolic, low diastolic) due to increased stroke volume and decreased systemic vascular resistance.
Q: Why use Propranolol specifically? A: It controls the heart rate AND blocks peripheral conversion of T4 to active T3.
75. Myxedema Facies
Diagnosis: Severe Hypothyroidism.
Pathognomonic Sign: Dull, puffy face, periorbital edema, macroglossia, and loss of the outer third of the eyebrows (madarosis).
Clinical Risk: Massive pericardial effusion, severe bradycardia, accelerated atherosclerosis.
Management: Gradual Levothyroxine replacement, echocardiogram to rule out tamponade.
Cross-Examination (5 Q&A):
Q: Do these large pericardial effusions typically cause tamponade? A: Surprisingly no; they accumulate very slowly, allowing the pericardium to stretch over time.
Q: What does the ECG show? A: Sinus bradycardia and diffuse low voltage.
Q: What happens to systemic vascular resistance? A: It increases significantly, which can worsen diastolic hypertension.
Q: Why is Levothyroxine started very slowly in elderly cardiac patients? A: Rapid metabolic acceleration can precipitate severe angina or acute myocardial infarction.
Q: What lipid abnormality is universally seen? A: Hypercholesterolemia (due to decreased LDL receptor expression).
76. Acromegaly Facies
Diagnosis: Acromegaly.
Pathognomonic Sign: Enlarged jaw (prognathism), prominent supraorbital ridges, macroglossia, and spade-like enlargement of the hands and feet.
Clinical Risk: Acromegalic Cardiomyopathy (biventricular hypertrophy), severe hypertension.
Management: Transsphenoidal tumor resection, somatostatin analogs, BP control.
Cross-Examination (5 Q&A):
Q: What causes the cardiomyopathy? A: Direct toxic effects of excess Growth Hormone (GH) and IGF-1 on the myocardium, plus secondary effects from hypertension.
Q: What is the echocardiographic hallmark? A: Concentric biventricular hypertrophy with diastolic dysfunction, progressing to a dilated phenotype late in the disease.
Q: Is the hypertrophy reversible? A: Yes, surgical cure of the adenoma can lead to significant regression of the hypertrophy.
Q: What arrhythmia is most common? A: Premature Ventricular Contractions (PVCs) and Atrial Fibrillation.
Q: What metabolic syndrome exacerbates the cardiac risk? A: Secondary Diabetes Mellitus (GH causes profound insulin resistance).
77. Moon Facies & Buffalo Hump
Diagnosis: Cushing's Syndrome.
Pathognomonic Sign: Rounded, plethoric face,dorsocervical fat pad,central obesity & broad purple abdominal striae.
Clinical Risk: Resistant hypertension, premature CAD, heart failure.
Management: Resection of the cortisol-secreting tumor or cessation of exogenous steroids.
Cross-Examination (5 Q&A):
Q: What is the mechanism of hypertension? A: Cortisol cross-reacts with mineralocorticoid receptors (sodium/water retention) and upregulates vascular alpha-1 receptors.
Q: What electrolyte abnormality accompanies the HTN? A: Hypokalemia (due to the mineralocorticoid effect).
Q: Why do these patients get premature CAD? A: Glucocorticoids induce insulin resistance, central obesity, and DL.
Q: What happens to the skin? A: Dermal atrophy leads to easily bruisable, thin skin and wide purple striae (unlike the pink striae of simple obesity).
Q: Does the cardiovascular risk immediately resolve upon cure? A: No, structural vascular changes often persist long after cortisol levels normalize.
78. Progeria Facies
Diagnosis: Hutchinson-Gilford Progeria Syndrome.
Pathognomonic Sign: Disproportionately large head, absent hair (alopecia), prominent scalp veins, small jaw, and aged-looking skin in a child.
Clinical Risk: Extreme premature atherosclerosis, leading to fatal MI or stroke in the 1st or 2nd decade of life.
Management: Farnesyltransferase inhibitors (Lonafarnib), low-dose aspirin, statins.
Cross-Examination (5 Q&A):
Q: What is the genetic defect? A: De novo mutation in the LMNA gene (Lamin A protein).
Q: What is the abnormal protein called? A: Progerin, which accumulates in the nuclear envelope causing cellular instability and rapid aging.
Q: Do these patients have high cholesterol? A: No, their lipid profiles are completely normal; the atherosclerosis is driven by vascular smooth muscle senescence.
Q: What does the arterial pathology show? A: Extreme calcification and stiffening of the aorta and coronary arteries, without classic lipid-rich plaques.
Q: What is the average life expectancy? A: Approximately 13-14 y, almost exclusively due to cardiovascular events.
79. Port-Wine Stain & Limb Hypertrophy
Diagnosis: Klippel-Trenaunay Syndrome.
Pathognomonic Sign: Classic triad of capillary malformations (port-wine stain), venous varicosities, and bone/soft tissue hypertrophy of an extremity (usually one leg).
Clinical Risk: Deep Vein Thrombosis (DVT), Pulmonary Embolism, High-output heart failure.
Management: Compression garments, lifelong anticoagulation if recurrent DVT, surgical debulking.
Cross-Examination (5 Q&A):
Q: How does this syndrome cause high-output heart failure? A: Through massive, anomalous arteriovenous malformations (AVMs) in the affected limb acting as a massive shunt.
Q: Differentiate from Parkes-Weber Syndrome? A: Parkes-Weber has clinically significant, high-flow macroscopic AVMs; Klippel-Trenaunay is predominantly low-flow venous/capillary malformations.
Q: Why are they at high risk for PE? A: Blood stasis in the massive, anomalous venous varicosities leads to recurrent DVTs.
Q: What happens to the affected limb's length? A: It grows significantly longer and wider than the unaffected limb.
Q: Can the AVMs be closed percutaneously? A: Yes, focal AVMs can be treated with transcatheter coil embolization to reduce cardiac output burden.
80. Congenital Rubella Syndrome
Diagnosis: Congenital Rubella.
Pathognomonic Sign: Classic triad of bilateral cataracts, sensorineural deafness, and congenital heart disease.
Clinical Risk: Patent Ductus Arteriosus (PDA), Branch Pulmonary Artery Stenosis.
Management: Transcatheter closure of PDA, balloon dilation of pulmonary stenoses.
Cross-Examination (5 Q&A):
Q: What is the most common cardiac defect? A: Patent Ductus Arteriosus (PDA).
Q: What is the second most common cardiac defect? A: Peripheral/Branch Pulmonary Artery Stenosis.
Q: When is the fetus most vulnerable to maternal rubella infection? A: The first trimester (especially the first 8 weeks).
Q: Does maternal vaccination during pregnancy prevent this? A: The MMR vaccine is a live attenuated virus and is strictly contraindicated during pregnancy.
Q: What type of murmur is heard with branch pulmonary stenosis? A: A continuous or long systolic murmur heard over the back or axillae (unlike a PDA murmur which is loudest at the left infraclavicular area).
81. Fetal Alcohol Syndrome
Diagnosis: Fetal Alcohol Syndrome (FAS).
Pathognomonic Sign: Smooth philtrum, thin vermilion border (upper lip), short palpebral fissures, and microcephaly.
Clinical Risk: Ventricular Septal Defect (VSD), Atrial Septal Defect (ASD).
Management: Echocardiographic screening, standard surgical or device closure if hemodynamically significant.
Cross-Examination (5 Q&A):
Q: What is the most common cardiac defect in FAS? A: Ventricular Septal Defect (VSD).
Q: Are complex, cyanotic congenital heart defects common in FAS? A: No, simple septal defects (VSD, ASD) account for the vast majority.
Q: What is the mechanism of teratogenicity? A: Alcohol crosses the placenta and disrupts cranial neural crest cell migration.
Q: Is there a safe threshold of alcohol consumption in pregnancy? A: No, absolute abstinence is recommended.
Q: What non-cardiac issue is universally present? A: Intellectual disability and severe behavioral/learning deficits.
82. Ellis-van Creveld Syndrome
Diagnosis: Chondroectodermal Dysplasia.
Pathognomonic Sign: Disproportionate short-limb dwarfism, postaxial polydactyly (extra digits), and dysplastic nails/teeth.
Clinical Risk: Common Atrium (Single Atrium), large ASD.
Management: Surgical reconstruction of the atrial septum.
Cross-Examination (5 Q&A):
Q: What cardiac defect is the hallmark of this syndrome? A: A massive ASD or a true Common Atrium (Single Atrium).
Q: What is the inheritance pattern? A: Autosomal recessive.
Q: Which population has an unusually high prevalence? A: The Amish population.
Q: Are ventricular septal defects common in this syndrome? A: Less common; the primary defect involves the atrial septum and endocardial cushions.
Q: Does it cause cyanosis? A: Mild cyanosis can occur due to bidirectional mixing in the common atrium.
83. TAR Syndrome
Diagnosis: Thrombocytopenia-Absent Radius Syndrome.
Pathognomonic Sign: Bilateral absence of the radius bone, BUT with preservation of the thumbs, alongside severe thrombocytopenia.
Clinical Risk: Tetralogy of Fallot, ASD.
Management: Platelet transfusions during infancy, surgical repair of ToF.
Cross-Examination (5 Q&A):
Q: How do you differentiate the limbs of TAR from Holt-Oram syndrome? A: In TAR syndrome, the thumbs are ALWAYS present; in Holt-Oram, the thumbs are absent or hypoplastic.
Q: What is the most common cardiac defect in TAR? A: Tetralogy of Fallot or an ASD (present in about 30% of patients).
Q: Does the thrombocytopenia persist lifelong? A: Usually, it improves significantly after the first year of life.
Q: What triggers severe bleeding episodes in these infants? A: Cow's milk allergy or viral infections.
Q: What is the surgical challenge for the cardiac defect? A: Timing the cardiopulmonary bypass around the bleeding risk and platelet count.
84. Rubinstein-Taybi Syndrome
Diagnosis: Rubinstein-Taybi Syndrome.
Pathognomonic Sign: Abnormally broad, angulated thumbs and great toes, with a highly arched palate and intellectual disability.
Clinical Risk: Patent Ductus Arteriosus (PDA), VSD, ASD.
Management: Standard echocardiographic screening and closure of defects.
Cross-Examination (5 Q&A):
Q: What is the genetic mechanism? A: Microdeletion at 16p13.3 or mutation in the CREBBP gene.
Q: What percentage of these patients have CHD? A: Approximately 30%.
Q: Is there a specific pathognomonic heart defect for this syndrome? A: No, it is usually a mix of simple defects (PDA, VSD, ASD).
Q: What anesthetic risk must the cardiologist/surgeon be aware of? A: High risk of difficult intubation due to the highly arched palate and micrognathia.
Q: What happens to the broad digits? A: They often deviate radially, causing functional impairment.
85. Alagille Syndrome
Diagnosis: Alagille Syndrome (Arteriohepatic Dysplasia).
Pathognomonic Sign: Bile duct paucity (severe jaundice), butterfly vertebrae on X-ray, and a triangular face with a broad, prominent forehead and pointed chin.
Clinical Risk: Peripheral Pulmonary Artery Stenosis, Tetralogy of Fallot.
Management: Balloon angioplasty or stenting of pulmonary branches; liver transplant if severe.
Cross-Examination (5 Q&A):
Q: What is the classic cardiovascular lesion? A: Branch/Peripheral Pulmonary Artery Stenosis.
Q: What genetic mutation is responsible? A: JAG1 gene mutation (Notch signaling pathway).
Q: What is the classic ocular finding? A: Posterior embryotoxon (a prominent Schwalbe's line in the anterior chamber).
Q: How is the murmur of peripheral pulmonary stenosis characterized? A: A systolic murmur heard best over the back and axillae, rather than the precordium.
Q: Why is cardiac surgery high risk? A: Concomitant severe liver disease causes profound coagulopathy and malnutrition.
86. Carney Complex
Diagnosis: Carney Complex.
Pathognomonic Sign: Spotty skin pigmentation (lentigines and blue nevi) on the face, lips, and conjunctiva, paired with endocrine overactivity (Cushing's/Acromegaly).
Clinical Risk: Multiple, recurrent Cardiac Myxomas.
Management: Aggressive, repeated surgical resection of myxomas.
Cross-Examination (5 Q&A):
Q: How do Carney Complex myxomas differ from sporadic myxomas? A: They present in younger patients, are often multiple, can occur in any chamber (not just the LA), and frequently recur after surgery.
Q: What is the genetic mutation? A: PRKAR1A gene mutation (Autosomal Dominant).
Q: What endocrine tumors are associated? A: Primary pigmented nodular adrenocortical disease (causing Cushing's) and pituitary adenomas.
Q: What non-cardiac tumor is a hallmark? A: Testicular large-cell calcifying Sertoli cell tumors.
Q: What is the screening protocol? A: Annual echocardiography for life, starting in infancy.
87. Arteriovenous Fistula (Dialysis Access)
Diagnosis: High-Output Heart Failure.
Pathognomonic Sign: A surgically created AV fistula (e.g., Cimino fistula) or a large traumatic AV fistula with a palpable thrill and continuous bruit.
Clinical Risk: Severe left ventricular volume overload, massive cardiomegaly, high-output heart failure.
Management: Surgical banding or ligation of the fistula if heart failure is refractory.
Cross-Examination (5 Q&A):
Q: What is the Nicoladoni-Branham sign? A: Manual compression of the fistula causes an immediate drop in heart rate (reflex bradycardia).
Q: Why does the heart rate drop when compressed? A: Occluding the fistula increases systemic vascular resistance, raising BP, which triggers vagal tone via baroreceptors.
Q: What defines high-output heart failure? A: Heart failure symptoms with a Cardiac Index > 4.0 L/min/m2.
Q: How does the pulse present? A: Bounding, water-hammer pulse with a very wide pulse pressure.
Q: Does the LV function usually recover after closure? A: Yes, if closed before irreversible myocardial fibrosis occurs.
88. Cardiac Tamponade (Sphygmomanometer OSCE)
Diagnosis: Pulsus Paradoxus.
Pathognomonic Sign: On a manual blood pressure cuff, the first Korotkoff sounds are heard only during expiration; as the cuff is deflated by > 10 mmHg, sounds are heard throughout the entire respiratory cycle.
Clinical Risk: Obstructive shock and death from cardiac tamponade.
Management: Immediate Echo-guided Pericardiocentesis.
Cross-Examination (5 Q&A):
Q: What is the definition of Pulsus Paradoxus? A: An inspiratory drop in systolic blood pressure greater than 10 mmHg.
Q: Why is the term "paradoxical" a misnomer? A: It is an exaggeration of a normal physiological phenomenon, not a true paradox.
Q: What is the physiological mechanism? A: Ventricular interdependence. Inspiration fills the fixed-volume pericardial sac with venous blood into the RV, pushing the septum into the LV, severely dropping LV stroke volume.
Q: What respiratory condition famously causes a pulsus paradoxus without tamponade? A: Severe asthma or COPD exacerbation (due to massive negative intrathoracic pressure swings).
Q: Can tamponade occur without a pulsus paradoxus? A: Yes, if there is an ASD, severe Aortic Regurgitation, or severe LV hypertrophy preventing septal shift.
89. Severe LV Failure (Pulse Palpation OSCE)
Diagnosis: Pulsus Alternans.
Pathognomonic Sign: Palpable alteration of the pulse amplitude (one strong beat followed by one weak beat) despite a perfectly regular, normal heart rate.
Clinical Risk: End-stage left ventricular systolic dysfunction, impending cardiogenic shock.
Management: GDMT for severe HFrEF, assess for LVAD or cardiac transplantation.
Cross-Examination (5 Q&A):
Q: What is the pathophysiology of pulsus alternans? A: Alternating numbers of recruiting myocardial fibers/calcium cycling during contraction of a severely failing LV.
Q: How do you clinically differentiate it from bigeminy? A: In bigeminy (a PVC every other beat), the rhythm is irregular (short-long intervals). Pulsus alternans has a perfectly regular rhythm.
Q: How can you enhance the detection of pulsus alternans? A: Have the patient sit or stand (decreases venous return), or hold their breath after a PVC.
Q: Can it be detected with a blood pressure cuff? A: Yes, stop inflating just below the peak systolic pressure; you will hear Korotkoff sounds at half the heart rate.
Q: Is it seen in right heart failure? A: No, it is exclusively a sign of severe left ventricular systolic failure.
90. Aortic Stenosis (Pulse Palpation OSCE)
Diagnosis: Pulsus Parvus et Tardus.
Pathognomonic Sign: Palpation of the carotid artery reveals a pulse that is weak/small amplitude (parvus) and delayed in its peak (tardus) relative to the apical impulse.
Clinical Risk: Severe, flow-limiting calcific aortic stenosis.
Management: Echocardiography to measure peak velocity and mean gradient; prepare for AVR/TAVR.
Cross-Examination (5 Q&A):
Q: Why is it best palpated in the carotid artery? A: Central arteries best reflect the true left ventricular ejection dynamics; peripheral arteries amplify the pulse wave, masking the delay.
Q: Is this sign reliable in the elderly? A: No, stiff, atherosclerotic non-compliant arteries in the elderly can falsely normalize the upstroke.
Q: What is a classic associated physical exam finding on the chest? A: An apical-carotid delay, and a palpable systolic thrill in the 2nd right intercostal space.
Q: What happens to the second heart sound (S2)? A: Paradoxical splitting (P2 occurs before A2) or a single, soft S2 due to immobile aortic leaflets.
Q: What is the Gallavardin phenomenon? A: The harsh murmur of AS radiates to the apex where it sounds high-pitched and musical, mimicking Mitral Regurgitation.
91. Levine's Sign
Diagnosis: Angina Pectoris / Acute Coronary Syndrome.
Pathognomonic Sign: The patient instinctively holds a clenched fist directly over their sternum when describing their chest pain.
Clinical Risk: Acute Myocardial Infarction, lethal arrhythmias.
Management: Immediate 12-lead ECG, troponin testing, and administration of sublingual nitroglycerin/aspirin.
Cross-Examination (5 Q&A):
Q: Why does the patient use a fist rather than pointing with a finger? A: Ischemic pain is visceral (poorly localized and diffuse), whereas somatic pain (like costochondritis) is easily localized with a single finger.
Q: Does the presence of Levine's sign guarantee ischemia? A: No, but it has a high positive predictive value for myocardial ischemia.
Q: What demographic classically presents with atypical symptoms instead of Levine's sign? A: Women, diabetics, and the elderly (who may present with dyspnea or fatigue).
Q: If the pain is sharp and pleuritic, is it likely angina? A: No, ischemic pain is classically described as pressure, heaviness, or squeezing.
Q: What autonomic signs often accompany this presentation? A: Diaphoresis, nausea, and severe anxiety (angor animi / impending doom).
92. Broadbent's Sign
Diagnosis: Adhesive Pericarditis / Constrictive Pericarditis.
Pathognomonic Sign: Visible systolic retraction of the left posterior-lateral lower ribs (around the 11th,12th ribs).
Clinical Risk: Severe right heart failure, low cardiac output.
Management: Echocardiography and right heart catheterization, followed by surgical pericardiectomy.
Cross-Examination (5 Q&A):
Q: What is the underlying mechanical cause? A: Extensive fibrous adhesions binding the pericardium to the diaphragm and the inner aspect of the posterior thoracic wall.
Q: When the ventricles contract, what happens? A: The adherent heart pulls the diaphragm and attached ribs inward during systole.
Q: How does this differ from the normal apical impulse? A: The normal impulse is an outward thrust in systole; Broadbent's is an inward retraction.
Q: Is it highly sensitive? A: No, it is a classic but rare sign seen only in advanced, severe adhesive disease.
Q: What historical infectious disease was the most common cause? A: Tuberculosis.
93. Pulsus Bisferiens
Diagnosis: Severe Aortic Regurgitation (often mixed with Aortic Stenosis) or Hypertrophic Obstructive Cardiomyopathy (HOCM).
Pathognomonic Sign: Palpation of the carotid artery reveals a "twin peak" (two distinct systolic impulses) with each heartbeat.
Clinical Risk: Hemodynamic compromise, sudden cardiac death (if HOCM).
Management: Echocardiography to determine the exact valvular or muscular etiology.
Cross-Examination (5 Q&A):
Q: What causes the two peaks in severe AR? A: The first peak is the rapid early systolic ejection; the second peak is a reflected wave from the periphery rebounding due to the massive stroke volume.
Q: What causes the two peaks in HOCM? A: The first peak is early rapid ejection, followed by a mid-systolic dip (due to sudden dynamic LVOT obstruction/SAM), and a second peak as the ventricle overcomes the obstruction.
Q: How do you differentiate the two clinically? A: HOCM will have a murmur that increases with Valsalva; AR has an early diastolic murmur and bounding peripheral pulses.
Q: Which artery is best for palpating this sign? A: The carotid or brachial artery (central arteries).
Q: What happens if you give a HOCM patient nitrates? A: The obstruction worsens, and the bisferiens pulse may become more pronounced.
94. Argyll Robertson Pupil
Diagnosis: Cardiovascular Syphilis (Tertiary Syphilis).
Pathognomonic Sign: Small, irregular pupils that accommodate to near vision but do not react to light (the "prostitute's pupil").
Clinical Risk: Syphilitic aortitis, aortic root aneurysm, severe Aortic Regurgitation.
Management: Penicillin G, surgical repair of the aortic root/valve.
Cross-Examination (5 Q&A):
Q: What part of the aorta is most commonly affected? A: The ascending aorta (rich in vasa vasorum).
Q: What is the classic gross pathological appearance of the aorta? A: "Tree-barking" (wrinkled intimal surface due to medial destruction and scarring).
Q: Why do these patients get coronary ischemia? A: The inflammatory aortitis causes severe stenosis of the coronary ostia, even if the distal vessels are clean.
Q: Does syphilitic aortitis typically cause aortic dissection? A: No, the extensive scarring and fibrosis actually prevent dissection, leading instead to massive saccular aneurysms.
Q: What murmur is heard? A: Early diastolic decrescendo murmur of Aortic Regurgitation (due to root dilation).
95. Calf Pseudohypertrophy
Diagnosis: Duchenne Muscular Dystrophy (DMD).
Pathognomonic Sign: Enlarged, firm calf muscles in a young boy who uses his hands to climb up his own legs to stand (Gowers' sign).
Clinical Risk: Progressive Dilated Cardiomyopathy and refractory heart failure in the late teens/twenties.
Management: ACE inhibitors/BB initiated early (even before echo changes); supportive respiratory care.
Cross-Examination (5 Q&A):
Q: Why is it called "pseudo" hypertrophy? A: The muscle enlargement is not true hypertrophy, but rather replacement of muscle fibers by fat and connective tissue.
Q: What is the genetic defect? A: X-linked recessive mutation causing an absence of the protein Dystrophin.
Q: What is the classic ECG finding in DMD? A: Tall R waves in V1 and deep Q waves in lateral leads (mimicking a true posterior MI).
Q: What causes the ECG changes? A: Early, selective scarring of the posterobasal left ventricle.
Q: How does Becker Muscular Dystrophy differ? A: Later onset, milder skeletal symptoms, but often presents with severe cardiomyopathy as the primary feature in adulthood.
96. Hatchet Facies & Frontal Baldness
Diagnosis: Myotonic Dystrophy (Type 1).
Pathognomonic Sign: A long, narrow face with hollowed cheeks (wasted masseter/temporalis muscles), ptosis, and frontal balding, accompanied by delayed grip relaxation (myotonia).
Clinical Risk: Progressive, unpredictable conduction system disease (Complete Heart Block) and Sudden Cardiac Death.
Management: Annual 12-lead ECG; low threshold for prophylactic pacemaker or ICD implantation.
Cross-Examination (5 Q&A):
Q: What is the genetic mutation? A: CTG trinucleotide repeat expansion in the DMPK gene (Autosomal Dominant).
Q: What is myotonia? A: The inability to rapidly relax a muscle after a voluntary contraction (e.g., getting stuck during a handshake).
Q: Does the severity of skeletal muscle weakness correlate with the cardiac risk? A: No, patients with mild skeletal disease can still suffer fatal AV block.
Q: What is the most common baseline ECG abnormality? A: First-degree AV block and prolonged QRS (bundle branch blocks).
Q: What intraoperative risk must the anesthesiologist manage? A: Extreme sensitivity to sedatives and depolarizing muscle relaxants, which can trigger severe myotonia or respiratory failure.
97. Erythema Migrans
Diagnosis: Lyme Carditis (Borrelia burgdorferi infection).
Pathognomonic Sign: An expanding, annular erythematous rash with central clearing (targetoid or "bulls-eye" lesion) occurring weeks after a tick bite.
Clinical Risk: Rapidly fluctuating, high-degree Atrioventricular (AV) block.
Management: IV Ceftriaxone for severe carditis; temporary transvenous pacing if hemodynamically unstable.
Cross-Examination (5 Q&A):
Q: Does the AV block require a permanent pacemaker? A: Rarely; the block is typically transient and resolves completely with antibiotic therapy.
Q: What part of the conduction system is affected? A: The AV node (usually above the bundle of His, so the escape rhythm is often narrow-complex).
Q: Can Lyme disease cause myocardial dysfunction? A: Yes, a mild, reversible myopericarditis can occur, though conduction issues are more prominent.
Q: What tick transmits the disease? A: Ixodes scapularis (deer tick).
Q: What stage of Lyme disease does carditis represent? A: Early disseminated stage (Stage 2).
98. Congenital Sensorineural Deafness
Diagnosis: Jervell and Lange-Nielsen Syndrome.
Pathognomonic Sign: Profound, bilateral sensorineural hearing loss in a young child.
Clinical Risk: Long QT Syndrome (specifically LQT1 variant) leading to Torsades de Pointes and Sudden Cardiac Death (often triggered by fright or exercise).
Management: High-dose Beta-blockers (Nadolol/Propranolol), ICD implantation, and strict avoidance of QT-prolonging medications.
Cross-Examination (5 Q&A):
Q: What is the genetic inheritance pattern? A: AR (mutations in KCNQ1 or KCNE1 potassium channel genes).
Q: How does this differ from Romano-Ward Syndrome? A: RWS is AD & features isolated LQT without deafness.
Q: Why does the mutation cause deafness? A: The potassium channels are required for maintaining endolymph homeostasis in the inner ear (stria vascularis).
Q: What is the classic trigger for syncope in LQT1? A: Swimming or sudden loud noises (like an alarm clock).
Q: Does a cochlear implant fix the cardiac risk? A: No, it only addresses the hearing loss; the malignant cardiac channelopathy persists.
99. Paget's Disease of Bone (Osteitis Deformans)
Diagnosis: High-Output Heart Failure.
Pathognomonic Sign: Enlarged skull (patient reports needing larger hats), prominent frontal bossing, and severe bowing of the tibias in an elderly patient.
Clinical Risk: High-output heart failure, severe calcific aortic stenosis.
Management: Bisphosphonates to halt bone turnover; manage heart failure and valve disease conventionally.
Cross-Examination (5 Q&A):
Q: What is the mechanism of high-output heart failure? A: The highly vascular, disorganized bone remodeling creates thousands of microscopic arteriovenous fistulas, dramatically lowering systemic vascular resistance.
Q: What happens to the pulse pressure? A: It is extremely wide, often mimicking Aortic Regurgitation.
Q: Why is Aortic Stenosis common? A: The disease process accelerates diffuse dystrophic calcification of the aortic root and valve.
Q: What lab marker is massively elevated? A: Serum Alkaline Phosphatase (with normal GGT and calcium).
Q: What is the most feared oncologic complication of this bone disease? A: Osteosarcoma.
100. Central Cyanosis
Diagnosis: Eisenmenger Syndrome / Anatomical Right-to-Left Shunt.
Pathognomonic Sign: Deep bluish discoloration of the highly vascular central mucous membranes (tongue, inner lips, buccal mucosa).
Clinical Risk: Severe hypoxia, secondary erythrocytosis (hyperviscosity syndrome), paradoxical emboli (stroke/brain abscess).
Management: Pulmonary vasodilators, phlebotomy only if hyperviscosity symptoms exist; heart-lung transplant.
Cross-Examination (5 Q&A):
Q: How does central cyanosis fundamentally differ from peripheral cyanosis? A: In central cyanosis, arterial blood leaving the left heart is already deoxygenated; in peripheral cyanosis, arterial blood is fully oxygenated, but sluggish flow causes excess tissue extraction.
Q: Does administering 100% oxygen resolve the cyanosis? A: No, because the desaturated blood physically bypasses the pulmonary capillary bed via the shunt.
Q: What level of deoxygenated hemoglobin causes visible cyanosis? A: Greater than 5 g/dL of absolute deoxygenated hemoglobin.
Q: Why is routine phlebotomy dangerous in these patients? A: It causes iron deficiency; iron-deficient red blood cells are less deformable, paradoxical worsening hyperviscosity and risk of stroke.
Q: What is the classic physical exam finding on the fingers? A: Severe, permanent digital clubbing.
Diagnosis: Familial Hypercholesterolemia (Heterozygous or Homozygous).
Pathognomonic Sign: Nodular swelling and thickening of the Achilles tendons or extensor tendons of the hands.
Clinical Risk: Premature severe coronary artery disease (often before age 40).
Management: High-intensity statins, Ezetimibe, PCSK9 inhibitors.
Cross-Examination (5 Q&A):
Diagnosis: Premature Corneal Arcus.
Pathognomonic Sign: Gray/white opaque ring around the peripheral cornea in a patient under 45 years old.
Clinical Risk: Strongly associated with severe dyslipidemia and premature CAD.
Management: Fasting lipid profile and aggressive lipid management.
Cross-Examination (5 Q&A):
Diagnosis: Diagonal Earlobe Crease.
Pathognomonic Sign: Deep, diagonal crease extending from the tragus across the lobule of the ear.
Clinical Risk: Epidemiological marker for underlying Coronary Artery Disease.
Management: Cardiovascular risk stratification (stress test or CCTA if symptomatic).
Cross-Examination (5 Q&A):
Diagnosis: Severe Aortic Regurgitation (Chronic).
Pathognomonic Sign: Visible capillary pulsation (alternating blanching and flushing) in the nail bed when gentle pressure is applied to the tip of the nail.
Clinical Risk: Left ventricular volume overload, eventual heart failure.
Management: Echocardiography to assess LV size and surgical timing.
Cross-Examination (5 Q&A):
Diagnosis: Severe Aortic Regurgitation.
Pathognomonic Sign: Bounding, forceful pulse with a rapid upstroke and rapid collapse (best felt at the radial or carotid artery).
Clinical Risk: LV dysfunction.
Management: Valve replacement when LV EF drops < 50% or LVESD > 50mm.
Cross-Examination (5 Q&A):
Diagnosis: Severe Aortic Regurgitation.
Pathognomonic Sign: Rhythmic nodding or bobbing of the head in synchrony with the heartbeat.
Clinical Risk: Correlates with large stroke volumes and severe AR.
Management: Aortic valve surgery workup.
Cross-Examination (5 Q&A):
Diagnosis: Constrictive Pericarditis, Right Ventricular Infarction, or Restrictive Cardiomyopathy.
Pathognomonic Sign: A paradoxical increase (or lack of the normal fall) in the Jugular Venous Pressure (JVP) during inspiration.
Clinical Risk: Severe right heart failure, low cardiac output.
Management: Echo and Right Heart Cath; Pericardiectomy if constrictive.
Cross-Examination (5 Q&A):
Diagnosis: Tricuspid Stenosis, Pulmonary Stenosis, or Right Ventricular Hypertrophy (RVH).
Pathognomonic Sign: A prominent presystolic pulsation in the jugular vein.
Clinical Risk: Right heart failure.
Management: Treat the underlying cause of RV pressure overload.
Cross-Examination (5 Q&A):
Diagnosis: Severe Tricuspid Regurgitation.
Pathognomonic Sign: A large, prominent systolic pulsation in the jugular vein that obliterates the normal 'x' descent (creating a merged 'cv' wave).
Clinical Risk: Hepatic congestion, ascites, peripheral edema.
Management: Diuretics, Tricuspid valve repair/replacement.
Cross-Examination (5 Q&A):
Diagnosis: Marfan Syndrome.
Pathognomonic Sign: Disproportionately long, spider-like fingers. Thumb sign (Steinberg): entire thumb protrudes beyond the ulnar border when folded in a fist. Wrist sign (Walker-Murdoch): thumb and pinky overlap when grasping the opposite wrist.
Clinical Risk: Aortic root aneurysm, aortic dissection, Mitral Valve Prolapse.
Management: Strict blood pressure control (Beta-blockers/ARBs), serial echocardiography, prophylactic aortic root replacement.
Cross-Examination (5 Q&A):
Diagnosis: Turner Syndrome (45,X).
Pathognomonic Sign: Broad neck with lateral skin folds, low posterior hairline, and a broad chest with widely spaced nipples.
Clinical Risk: Coarctation of the aorta, Bicuspid Aortic Valve (BAV).
Management: Lifelong cardiac screening, hypertension management.
Cross-Examination (5 Q&A):
Diagnosis: Trisomy 21 (Down Syndrome).
Pathognomonic Sign: Upward slanting palpebral fissures, epicanthal folds, flat nasal bridge, and macroglossia.
Clinical Risk: Endocardial Cushion Defects (Complete AV Canal).
Management: Early surgical repair of congenital defects to prevent fixed pulmonary hypertension.
Cross-Examination (5 Q&A):
Diagnosis: Patent Ductus Arteriosus (PDA) with Eisenmenger Syndrome.
Pathognomonic Sign: Pink upper extremities (normal oxygenation) and cyanotic, clubbed lower extremities.
Clinical Risk: Right heart failure, paradoxical emboli to the lower body, death.
Management: Palliative care, heart-lung transplantation (defect closure is strictly contraindicated).
Cross-Examination (5 Q&A):
Diagnosis: Severe Hypertriglyceridemia (often Type I or V hyperlipidemia).
Pathognomonic Sign: Crops of small, red-yellow papules on an erythematous base, typically on the extensor surfaces of arms, legs, and buttocks.
Clinical Risk: Acute pancreatitis (highest risk), premature CAD.
Management: Fibrates, Omega-3 fatty acids, strict glycemic control, and dietary fat restriction.
Cross-Examination (5 Q&A):
Diagnosis: Dyslipidemia (often familial, though 50% have normal lipids).
Pathognomonic Sign: Soft, yellowish, cholesterol-filled plaques on the medial aspects of the eyelids.
Clinical Risk: Independent risk marker for Coronary Artery Disease and myocardial infarction.
Management: Complete lipid profile assessment and CAD risk stratification.
Cross-Examination (5 Q&A):
Diagnosis: Infective Endocarditis.
Pathognomonic Sign: Retinal hemorrhages with pale, white/yellow centers seen on fundoscopic exam.
Clinical Risk: Systemic embolization, severe valvular destruction.
Management: Blood cultures, TEE, IV antibiotics.
Cross-Examination (5 Q&A):
Diagnosis: Carotid Artery Atherosclerosis / Embolic Disease.
Pathognomonic Sign: Small, bright, highly refractile golden-yellow crystals lodged at the bifurcations of retinal arterioles.
Clinical Risk: Amaurosis fugax, Transient Ischemic Attack (TIA), stroke.
Management: Carotid Doppler ultrasound, antiplatelets, high-intensity statin.
Cross-Examination (5 Q&A):
Diagnosis: Atheroembolic Disease (Cholesterol Embolization Syndrome) or Vasculitis.
Pathognomonic Sign: Mottled, purplish, lace-like (reticular) discoloration of the skin, most prominent on the lower extremities.
Clinical Risk: Acute kidney injury, bowel ischemia, limb loss.
Management: Discontinue anticoagulation (if applicable), supportive care, statins.
Cross-Examination (5 Q&A):
Diagnosis: Atheroembolic Disease / Microvascular Thrombosis.
Pathognomonic Sign: Sudden onset of painful, cyanotic, or purpuric toes in the presence of palpable pedal pulses.
Clinical Risk: Tissue necrosis, gangrene.
Management: Avoid anticoagulants, use statins, treat pain, allow demarcation.
Cross-Examination (5 Q&A):
Diagnosis: Right Ventricular Failure / Elevated Left-Sided Filling Pressures.
Pathognomonic Sign: Sustained elevation of the JVP (greater than 3 cm for >15 seconds) during firm, continuous pressure over the mid-abdomen.
Clinical Risk: Decompensated heart failure.
Management: Intravenous loop diuretics, afterload reduction.
Cross-Examination (5 Q&A):
Diagnosis: Marfan Syndrome or Mitral Valve Prolapse.
Pathognomonic Sign: Caved-in or sunken appearance of the chest (funnel chest).
Clinical Risk: Right heart compression (if severe), aortic root dilation (if Marfan).
Management: Echo to rule out MVP and measure aortic root; surgical Nuss procedure if cardiopulmonary compromise exists.
Cross-Examination (5 Q&A):
Diagnosis: Williams-Beuren Syndrome.
Pathognomonic Sign: "Elfin" facies (broad forehead, short nose with broad tip, full cheeks, wide mouth with full lips).
Clinical Risk: Supravalvular Aortic Stenosis (SVAS), peripheral pulmonary stenosis, sudden cardiac death.
Management: Surgical repair of SVAS; monitor calcium levels.
Cross-Examination (5 Q&A):
Diagnosis: Noonan Syndrome.
Pathognomonic Sign: Webbed neck, short stature, low-set ears, hypertelorism, and ptosis (often called "Male Turner syndrome," though it affects both sexes).
Clinical Risk: Dysplastic Pulmonary Valve Stenosis, Hypertrophic Cardiomyopathy (HCM).
Management: Balloon valvuloplasty (though less effective than in typical PS) or surgical valve replacement.
Cross-Examination (5 Q&A):
Diagnosis: Holt-Oram Syndrome (Heart-Hand Syndrome).
Pathognomonic Sign: Upper limb abnormalities (absent, hypoplastic, or triphalangeal thumbs) paired with congenital heart disease.
Clinical Risk: Right heart volume overload, heart block.
Management: Surgical/device closure of septal defects, Holter monitor for AV block.
Cross-Examination (5 Q&A):
Diagnosis: DiGeorge Syndrome (CATCH-22).
Pathognomonic Sign: Cleft palate, micrognathia, low-set ears, tubular nose.
Clinical Risk: Conotruncal cardiac anomalies, severe hypocalcemia, immunodeficiency.
Management: Complex surgical repair of outflow tracts, calcium supplementation.
Cross-Examination (5 Q&A):
Diagnosis: Loeys-Dietz Syndrome.
Pathognomonic Sign: Bifid uvula, cleft palate, hypertelorism, and generalized arterial tortuosity.
Clinical Risk: Highly aggressive aortic and arterial aneurysms/dissections at a young age.
Management: Early prophylactic aortic root replacement (at smaller diameters than Marfan).
Cross-Examination (5 Q&A):
Diagnosis: Vascular Ehlers-Danlos Syndrome.
Pathognomonic Sign: Thin, translucent skin, prominent venous pattern, characteristic facial appearance (thin lips, small chin, pinched nose).
Clinical Risk: Spontaneous rupture of arteries (aorta, coronaries), bowel, or gravid uterus.
Management: Strict blood pressure control, avoidance of invasive vascular procedures (extreme risk of vessel tearing).
Cross-Examination (5 Q&A):
Diagnosis: PXE.
Pathognomonic Sign: "Plucked chicken" skin appearance (yellowish papules coalescing into plaques on the neck and flexural creases).
Clinical Risk: Premature coronary artery disease, claudication, restrictive cardiomyopathy.
Management: Risk factor modification, anti-VEGF for ocular complications.
Cross-Examination (5 Q&A):
Diagnosis: HHT.
Pathognomonic Sign: Multiple pinpoint telangiectasias on the lips, tongue, face, and fingers.
Clinical Risk: Pulmonary Arteriovenous Malformations (PAVMs), severe epistaxis, high-output heart failure.
Management: Transcatheter embolization of PAVMs, iron replacement.
Cross-Examination (5 Q&A):
Diagnosis: Primary (AL) Amyloidosis.
Pathognomonic Sign: Purpura/ecchymosis around the eyes, especially after minor trauma, coughing, or Valsalva (Pinch purpura).
Clinical Risk: Restrictive cardiomyopathy, severe arrhythmias, rapidly progressive heart failure.
Management: Bone marrow biopsy, chemotherapy, autologous stem cell transplant.
Cross-Examination (5 Q&A):
Diagnosis: Primary (AL) Amyloidosis.
Pathognomonic Sign: Massively enlarged, firm, easily indentable tongue (often with tooth indentations on the lateral borders).
Clinical Risk: Airway obstruction, restrictive heart failure.
Management: Tissue biopsy (fat pad or tongue) with Congo Red staining.
Cross-Examination (5 Q&A):
Diagnosis: Carcinoid Syndrome.
Pathognomonic Sign: Episodic, bright red flushing of the face, neck, and upper chest, often accompanied by wheezing and diarrhea.
Clinical Risk: Severe Right Heart Failure (Tricuspid Regurgitation / Pulmonary Stenosis).
Management: Somatostatin analogs (Octreotide), valve replacement surgery.
Cross-Examination (5 Q&A):
Diagnosis: Tuberous Sclerosis Complex (TSC).
Pathognomonic Sign: Facial angiofibromas (adenoma sebaceum), ash-leaf spots (hypomelanotic macules), and Shagreen patches.
Clinical Risk: Cardiac Rhabdomyoma leading to outflow tract obstruction or arrhythmias in infancy.
Management: Observation (tumors usually regress), mTOR inhibitors (Everolimus) if obstructive.
Cross-Examination (5 Q&A):
Diagnosis: Congenital Complete Heart Block.
Pathognomonic Sign: Annular erythematous plaques on the scalp/face of a neonate, accompanied by profound bradycardia.
Clinical Risk: Permanent Complete Heart Block, heart failure (hydrops fetalis).
Management: Permanent epicardial pacemaker implantation in the neonate.
Cross-Examination (5 Q&A):
Diagnosis: Ankylosing Spondylitis.
Pathognomonic Sign: "Question mark" posture (exaggerated thoracic kyphosis, loss of lumbar lordosis) and fixed neck flexion.
Clinical Risk: Aortitis, severe Aortic Regurgitation, AV block.
Management: Echocardiography, aortic valve replacement if indicated, permanent pacing for block.
Cross-Examination (5 Q&A):
Diagnosis: Marfan Syndrome (or severe childhood asthma).
Pathognomonic Sign: Outward protrusion of the sternum and ribs ("pigeon chest").
Clinical Risk: Aortic root dilation, MVP.
Management: Echocardiography for aortic root dimensions.
Cross-Examination (5 Q&A):
Diagnosis: Turner Syndrome (45,X).
Pathognomonic Sign: Puffy, swollen hands and feet in a newborn female.
Clinical Risk: Coarctation of the aorta, Bicuspid Aortic Valve.
Management: 4-limb blood pressures, Echocardiogram.
Cross-Examination (5 Q&A):
Diagnosis: Friedreich's Ataxia.
Pathognomonic Sign: Unusually high arches of the feet (pes cavus), hammer toes, and progressive spinal curvature.
Clinical Risk: Concentric Hypertrophic Cardiomyopathy, heart failure, arrhythmias.
Management: Echocardiogram, symptom management (no cure).
Cross-Examination (5 Q&A):
Diagnosis: Acute Rheumatic Fever (ARF).
Pathognomonic Sign: Non-pruritic, pink, macular rings with central clearing and serpiginous spreading margins, primarily on the trunk and proximal limbs (sparing the face).
Clinical Risk: Severe pancarditis, leading to chronic rheumatic heart disease (MS, MR, AS, AR).
Management: Penicillin G (eradication of Strep), high-dose aspirin (polyarthritis), and corticosteroids (severe carditis).
Cross-Examination (5 Q&A):
Diagnosis: Acute Rheumatic Fever (ARF).
Pathognomonic Sign: Firm, painless, mobile nodules (0.5 to 2.0 cm) located over the extensor surfaces of joints, scalp, and spine.
Clinical Risk: Strongly correlates with the presence of severe rheumatic carditis.
Management: Treat the underlying ARF; nodules resolve spontaneously within weeks.
Cross-Examination (5 Q&A):
Diagnosis: Acute Rheumatic Fever (Late manifestation).
Pathognomonic Sign: Rapid, irregular, purposeless, and involuntary movements of the limbs and face, accompanied by emotional lability.
Clinical Risk: High incidence of concurrent or subsequent rheumatic mitral valve disease.
Management: Quiet environment, valproic acid or haloperidol if severe; secondary penicillin prophylaxis is mandatory.
Cross-Examination (5 Q&A):
Diagnosis: LEOPARD Syndrome (Noonan Syndrome with Multiple Lentigines).
Pathognomonic Sign: Thousands of dark brown freckles (lentigines) covering the head, neck, and trunk, appearing in childhood and sparing the mucous membranes.
Clinical Risk: Hypertrophic Cardiomyopathy (HCM) and Dysplastic Pulmonary Stenosis (PS).
Management: Serial echocardiography, beta-blockers for HCM/LVOT obstruction.
Cross-Examination (5 Q&A):
Diagnosis: Osteogenesis Imperfecta (Type 1).
Pathognomonic Sign: Deep blue or grayish-blue discoloration of the sclera due to thinning of the collagen layer, revealing the underlying uveal tract.
Clinical Risk: Aortic root dilation, aortic regurgitation, and mitral valve prolapse.
Management: Echocardiographic surveillance of the aortic root; bisphosphonates for bone fragility.
Cross-Examination (5 Q&A):
Diagnosis: Hemochromatosis ("Bronze Diabetes").
Pathognomonic Sign: Slate-gray to bronze hyperpigmentation of the skin, most prominent in sun-exposed areas and genitalia.
Clinical Risk: Restrictive Cardiomyopathy initially, progressing to Dilated Cardiomyopathy and refractory arrhythmias.
Management: Phlebotomy, iron chelation (Deferoxamine), and heart failure therapies.
Cross-Examination (5 Q&A):
Diagnosis: Systemic Sclerosis / CREST Syndrome.
Pathognomonic Sign: Tight, thickened, shiny skin over the fingers (sclerodactyly) preventing full extension, paired with microstomia (small mouth) and facial telangiectasias.
Clinical Risk: Pulmonary Arterial Hypertension (PAH), myocardial fibrosis, and pericardial effusions.
Management: Right Heart Catheterization (RHC) for PAH diagnosis; endothelin receptor antagonists or PDE-5 inhibitors.
Cross-Examination (5 Q&A):
Diagnosis: Systemic Lupus Erythematosus (SLE).
Pathognomonic Sign: Erythematous, scaling rash across the bridge of the nose and cheeks, classically sparing the nasolabial folds.
Clinical Risk: Libman-Sacks endocarditis, premature CAD, acute pericarditis.
Management: Corticosteroids, hydroxychloroquine, screening echocardiogram.
Cross-Examination (5 Q&A):
Diagnosis: Graves' Disease (Severe Thyrotoxicosis).
Pathognomonic Sign: Proptosis (bulging eyes), lid retraction, and a diffusely enlarged thyroid gland, often with a thyroid bruit.
Clinical Risk: High-output heart failure, Atrial Fibrillation.
Management: Beta-blockers (Propranolol) for rate control and symptom relief, antithyroid drugs (Methimazole).
Cross-Examination (5 Q&A):
Diagnosis: Severe Hypothyroidism.
Pathognomonic Sign: Dull, puffy face, periorbital edema, macroglossia, and loss of the outer third of the eyebrows (madarosis).
Clinical Risk: Massive pericardial effusion, severe bradycardia, accelerated atherosclerosis.
Management: Gradual Levothyroxine replacement, echocardiogram to rule out tamponade.
Cross-Examination (5 Q&A):
Diagnosis: Acromegaly.
Pathognomonic Sign: Enlarged jaw (prognathism), prominent supraorbital ridges, macroglossia, and spade-like enlargement of the hands and feet.
Clinical Risk: Acromegalic Cardiomyopathy (biventricular hypertrophy), severe hypertension.
Management: Transsphenoidal tumor resection, somatostatin analogs, BP control.
Cross-Examination (5 Q&A):
Diagnosis: Cushing's Syndrome.
Pathognomonic Sign: Rounded, plethoric face,dorsocervical fat pad,central obesity & broad purple abdominal striae.
Clinical Risk: Resistant hypertension, premature CAD, heart failure.
Management: Resection of the cortisol-secreting tumor or cessation of exogenous steroids.
Cross-Examination (5 Q&A):
Diagnosis: Hutchinson-Gilford Progeria Syndrome.
Pathognomonic Sign: Disproportionately large head, absent hair (alopecia), prominent scalp veins, small jaw, and aged-looking skin in a child.
Clinical Risk: Extreme premature atherosclerosis, leading to fatal MI or stroke in the 1st or 2nd decade of life.
Management: Farnesyltransferase inhibitors (Lonafarnib), low-dose aspirin, statins.
Cross-Examination (5 Q&A):
Diagnosis: Klippel-Trenaunay Syndrome.
Pathognomonic Sign: Classic triad of capillary malformations (port-wine stain), venous varicosities, and bone/soft tissue hypertrophy of an extremity (usually one leg).
Clinical Risk: Deep Vein Thrombosis (DVT), Pulmonary Embolism, High-output heart failure.
Management: Compression garments, lifelong anticoagulation if recurrent DVT, surgical debulking.
Cross-Examination (5 Q&A):
Diagnosis: Congenital Rubella.
Pathognomonic Sign: Classic triad of bilateral cataracts, sensorineural deafness, and congenital heart disease.
Clinical Risk: Patent Ductus Arteriosus (PDA), Branch Pulmonary Artery Stenosis.
Management: Transcatheter closure of PDA, balloon dilation of pulmonary stenoses.
Cross-Examination (5 Q&A):
Diagnosis: Fetal Alcohol Syndrome (FAS).
Pathognomonic Sign: Smooth philtrum, thin vermilion border (upper lip), short palpebral fissures, and microcephaly.
Clinical Risk: Ventricular Septal Defect (VSD), Atrial Septal Defect (ASD).
Management: Echocardiographic screening, standard surgical or device closure if hemodynamically significant.
Cross-Examination (5 Q&A):
Diagnosis: Chondroectodermal Dysplasia.
Pathognomonic Sign: Disproportionate short-limb dwarfism, postaxial polydactyly (extra digits), and dysplastic nails/teeth.
Clinical Risk: Common Atrium (Single Atrium), large ASD.
Management: Surgical reconstruction of the atrial septum.
Cross-Examination (5 Q&A):
Diagnosis: Thrombocytopenia-Absent Radius Syndrome.
Pathognomonic Sign: Bilateral absence of the radius bone, BUT with preservation of the thumbs, alongside severe thrombocytopenia.
Clinical Risk: Tetralogy of Fallot, ASD.
Management: Platelet transfusions during infancy, surgical repair of ToF.
Cross-Examination (5 Q&A):
Diagnosis: Rubinstein-Taybi Syndrome.
Pathognomonic Sign: Abnormally broad, angulated thumbs and great toes, with a highly arched palate and intellectual disability.
Clinical Risk: Patent Ductus Arteriosus (PDA), VSD, ASD.
Management: Standard echocardiographic screening and closure of defects.
Cross-Examination (5 Q&A):
Diagnosis: Alagille Syndrome (Arteriohepatic Dysplasia).
Pathognomonic Sign: Bile duct paucity (severe jaundice), butterfly vertebrae on X-ray, and a triangular face with a broad, prominent forehead and pointed chin.
Clinical Risk: Peripheral Pulmonary Artery Stenosis, Tetralogy of Fallot.
Management: Balloon angioplasty or stenting of pulmonary branches; liver transplant if severe.
Cross-Examination (5 Q&A):
Diagnosis: Carney Complex.
Pathognomonic Sign: Spotty skin pigmentation (lentigines and blue nevi) on the face, lips, and conjunctiva, paired with endocrine overactivity (Cushing's/Acromegaly).
Clinical Risk: Multiple, recurrent Cardiac Myxomas.
Management: Aggressive, repeated surgical resection of myxomas.
Cross-Examination (5 Q&A):
Diagnosis: High-Output Heart Failure.
Pathognomonic Sign: A surgically created AV fistula (e.g., Cimino fistula) or a large traumatic AV fistula with a palpable thrill and continuous bruit.
Clinical Risk: Severe left ventricular volume overload, massive cardiomegaly, high-output heart failure.
Management: Surgical banding or ligation of the fistula if heart failure is refractory.
Cross-Examination (5 Q&A):
Diagnosis: Pulsus Paradoxus.
Pathognomonic Sign: On a manual blood pressure cuff, the first Korotkoff sounds are heard only during expiration; as the cuff is deflated by > 10 mmHg, sounds are heard throughout the entire respiratory cycle.
Clinical Risk: Obstructive shock and death from cardiac tamponade.
Management: Immediate Echo-guided Pericardiocentesis.
Cross-Examination (5 Q&A):
Diagnosis: Pulsus Alternans.
Pathognomonic Sign: Palpable alteration of the pulse amplitude (one strong beat followed by one weak beat) despite a perfectly regular, normal heart rate.
Clinical Risk: End-stage left ventricular systolic dysfunction, impending cardiogenic shock.
Management: GDMT for severe HFrEF, assess for LVAD or cardiac transplantation.
Cross-Examination (5 Q&A):
Diagnosis: Pulsus Parvus et Tardus.
Pathognomonic Sign: Palpation of the carotid artery reveals a pulse that is weak/small amplitude (parvus) and delayed in its peak (tardus) relative to the apical impulse.
Clinical Risk: Severe, flow-limiting calcific aortic stenosis.
Management: Echocardiography to measure peak velocity and mean gradient; prepare for AVR/TAVR.
Cross-Examination (5 Q&A):
Diagnosis: Angina Pectoris / Acute Coronary Syndrome.
Pathognomonic Sign: The patient instinctively holds a clenched fist directly over their sternum when describing their chest pain.
Clinical Risk: Acute Myocardial Infarction, lethal arrhythmias.
Management: Immediate 12-lead ECG, troponin testing, and administration of sublingual nitroglycerin/aspirin.
Cross-Examination (5 Q&A):
Diagnosis: Adhesive Pericarditis / Constrictive Pericarditis.
Pathognomonic Sign: Visible systolic retraction of the left posterior-lateral lower ribs (around the 11th,12th ribs).
Clinical Risk: Severe right heart failure, low cardiac output.
Management: Echocardiography and right heart catheterization, followed by surgical pericardiectomy.
Cross-Examination (5 Q&A):
Diagnosis: Severe Aortic Regurgitation (often mixed with Aortic Stenosis) or Hypertrophic Obstructive Cardiomyopathy (HOCM).
Pathognomonic Sign: Palpation of the carotid artery reveals a "twin peak" (two distinct systolic impulses) with each heartbeat.
Clinical Risk: Hemodynamic compromise, sudden cardiac death (if HOCM).
Management: Echocardiography to determine the exact valvular or muscular etiology.
Cross-Examination (5 Q&A):
Diagnosis: Cardiovascular Syphilis (Tertiary Syphilis).
Pathognomonic Sign: Small, irregular pupils that accommodate to near vision but do not react to light (the "prostitute's pupil").
Clinical Risk: Syphilitic aortitis, aortic root aneurysm, severe Aortic Regurgitation.
Management: Penicillin G, surgical repair of the aortic root/valve.
Cross-Examination (5 Q&A):
Diagnosis: Duchenne Muscular Dystrophy (DMD).
Pathognomonic Sign: Enlarged, firm calf muscles in a young boy who uses his hands to climb up his own legs to stand (Gowers' sign).
Clinical Risk: Progressive Dilated Cardiomyopathy and refractory heart failure in the late teens/twenties.
Management: ACE inhibitors/BB initiated early (even before echo changes); supportive respiratory care.
Cross-Examination (5 Q&A):
Diagnosis: Myotonic Dystrophy (Type 1).
Pathognomonic Sign: A long, narrow face with hollowed cheeks (wasted masseter/temporalis muscles), ptosis, and frontal balding, accompanied by delayed grip relaxation (myotonia).
Clinical Risk: Progressive, unpredictable conduction system disease (Complete Heart Block) and Sudden Cardiac Death.
Management: Annual 12-lead ECG; low threshold for prophylactic pacemaker or ICD implantation.
Cross-Examination (5 Q&A):
Diagnosis: Lyme Carditis (Borrelia burgdorferi infection).
Pathognomonic Sign: An expanding, annular erythematous rash with central clearing (targetoid or "bulls-eye" lesion) occurring weeks after a tick bite.
Clinical Risk: Rapidly fluctuating, high-degree Atrioventricular (AV) block.
Management: IV Ceftriaxone for severe carditis; temporary transvenous pacing if hemodynamically unstable.
Cross-Examination (5 Q&A):
Diagnosis: Jervell and Lange-Nielsen Syndrome.
Pathognomonic Sign: Profound, bilateral sensorineural hearing loss in a young child.
Clinical Risk: Long QT Syndrome (specifically LQT1 variant) leading to Torsades de Pointes and Sudden Cardiac Death (often triggered by fright or exercise).
Management: High-dose Beta-blockers (Nadolol/Propranolol), ICD implantation, and strict avoidance of QT-prolonging medications.
Cross-Examination (5 Q&A):
Diagnosis: High-Output Heart Failure.
Pathognomonic Sign: Enlarged skull (patient reports needing larger hats), prominent frontal bossing, and severe bowing of the tibias in an elderly patient.
Clinical Risk: High-output heart failure, severe calcific aortic stenosis.
Management: Bisphosphonates to halt bone turnover; manage heart failure and valve disease conventionally.
Cross-Examination (5 Q&A):
Diagnosis: Eisenmenger Syndrome / Anatomical Right-to-Left Shunt.
Pathognomonic Sign: Deep bluish discoloration of the highly vascular central mucous membranes (tongue, inner lips, buccal mucosa).
Clinical Risk: Severe hypoxia, secondary erythrocytosis (hyperviscosity syndrome), paradoxical emboli (stroke/brain abscess).
Management: Pulmonary vasodilators, phlebotomy only if hyperviscosity symptoms exist; heart-lung transplant.
Cross-Examination (5 Q&A):
Comments
Post a Comment
Join the academic discussion. Share your clinical insights, questions, or perspectives below.